{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:32:40Z","timestamp":1789475560515,"version":"build-2803163510"},"reference-count":184,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s00228-026-03998-9","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T02:53:08Z","timestamp":1771901588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Clinical pharmacology of antiplatelet drugs: implications for personalized therapy"],"prefix":"10.1007","volume":"82","author":[{"given":"Surasak","family":"Wichaiyo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"issue":"6","key":"3998_CR1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1080\/10408363.2016.1200008","volume":"53","author":"XR Xu","year":"2016","unstructured":"Xu XR, Zhang D, Oswald BE, Carrim N, Wang X, Hou Y, Zhang Q, Lavalle C, McKeown T, Marshall AH, Ni H (2016) Platelets are versatile cells: New discoveries in hemostasis, thrombosis, immune responses, tumor metastasis and beyond. Crit Rev Clin Lab Sci 53(6):409\u2013430. https:\/\/doi.org\/10.1080\/10408363.2016.1200008","journal-title":"Crit Rev Clin Lab Sci"},{"key":"3998_CR2","volume-title":"Goodman & Gilman\u2019s the pharmacological basis of therapeutics","author":"LS Goodman","year":"2018","unstructured":"Goodman LS, Gilman A, Brunton LL, Hilal-Dandan R, Knollmann BC (2018) Goodman & Gilman\u2019s the pharmacological basis of therapeutics. McGraw Hill Education, New York. [etc.]"},{"issue":"2","key":"3998_CR3","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1160\/TH09-03-0192","volume":"102","author":"LK Jennings","year":"2009","unstructured":"Jennings LK (2009) Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis. Thromb Haemost 102(2):248\u2013257.","journal-title":"Thromb Haemost"},{"issue":"1","key":"3998_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/0192623310389474","volume":"39","author":"AJ Gale","year":"2011","unstructured":"Gale AJ (2011) Continuing education course #2: current understanding of hemostasis. Toxicol Pathol 39(1):273\u2013280. https:\/\/doi.org\/10.1177\/0192623310389474","journal-title":"Toxicol Pathol"},{"key":"3998_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12959-015-0048-y","volume":"13","author":"Y Wu","year":"2015","unstructured":"Wu Y (2015) Contact pathway of coagulation and inflammation. Thromb J 13:17.","journal-title":"Thromb J"},{"issue":"18","key":"3998_CR6","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1056\/NEJMra1011670","volume":"364","author":"JI ten Borissoff","year":"2011","unstructured":"Borissoff JI, Spronk HM, ten Cate H (2011) The hemostatic system as a modulator of atherosclerosis. N Engl J Med 364(18):1746\u20131760. https:\/\/doi.org\/10.1056\/NEJMra1011670","journal-title":"N Engl J Med"},{"issue":"7","key":"3998_CR7","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1021\/acsptsci.3c00052","volume":"6","author":"S Wichaiyo","year":"2023","unstructured":"Wichaiyo S, Parichatikanond W, Visansirikul S, Saengklub N, Rattanavipanon W (2023) Determination of the Potential Clinical Benefits of Small Molecule Factor XIa Inhibitors in Arterial Thrombosis. ACS Pharmacol Translational Sci 6(7):970\u2013981.https:\/\/doi.org\/10.1021\/acsptsci.3c00052","journal-title":"ACS Pharmacol Translational Sci"},{"issue":"3","key":"3998_CR8","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1124\/pr.117.014530","volume":"70","author":"J Yeung","year":"2018","unstructured":"Yeung J, Li W, Holinstat M (2018) Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases. Pharmacol Rev 70(3):526\u2013548. https:\/\/doi.org\/10.1124\/pr.117.014530","journal-title":"Pharmacol Rev"},{"issue":"11","key":"3998_CR9","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1161\/STROKEAHA.122.039790","volume":"53","author":"S Wichaiyo","year":"2022","unstructured":"Wichaiyo S, Parichatikanond W, Rattanavipanon W (2022) Glenzocimab: A GPVI (Glycoprotein VI)-Targeted Potential Antiplatelet Agent for the Treatment of Acute Ischemic Stroke. Stroke 53(11):3506\u20133513. https:\/\/doi.org\/10.1161\/strokeaha.122.039790","journal-title":"Stroke"},{"issue":"5","key":"3998_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.29090\/psa.2021.05.21.023","volume":"48","author":"S Wichaiyo","year":"2021","unstructured":"Wichaiyo S, Maiuthed A (2021) Pathological roles of platelets in inflammatory diseases: The emerging targets for new drug development. Pharm Sci Asia 48(5):402\u2013412. https:\/\/doi.org\/10.29090\/psa.2021.05.21.023","journal-title":"Pharm Sci Asia"},{"key":"3998_CR11","doi-asserted-by":"publisher","unstructured":"Kalantzi KI, Tsoumani ME, Goudevenos IA, Tselepis AD (2012) Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives. Expert Rev Clin Pharmacol 5 (3): 319\u2013336 https:\/\/doi.org\/10.1586\/ecp.12.19","DOI":"10.1586\/ecp.12.19"},{"issue":"10","key":"3998_CR12","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1161\/01.CIR.101.10.1206","volume":"101","author":"EH Awtry","year":"2000","unstructured":"Awtry EH, Loscalzo J (2000) Aspirin Circulation 101(10):1206\u20131218","journal-title":"Aspirin Circulation"},{"key":"3998_CR13","doi-asserted-by":"publisher","unstructured":"Koenig-Oberhuber V, Filipovic M (2016) New antiplatelet drugs and new oral anticoagulants. Br J Anaesth 117 Suppl 2: ii74-ii84 DOI 10.1093\/bja\/aew214 https:\/\/doi.org\/10.1093\/bja\/aew214","DOI":"10.1093\/bja\/aew214"},{"key":"3998_CR14","doi-asserted-by":"publisher","unstructured":"Morris T, Stables M, Gilroy DW (2006) New perspectives on aspirin and the endogenous control of acute inflammatory resolution. TheScientificWorldJournal 6: 1048\u20131065 DOI 10.1100\/tsw.2006.192 https:\/\/doi.org\/10.1100\/tsw.2006.192","DOI":"10.1100\/tsw.2006.192"},{"issue":"5","key":"3998_CR15","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1073\/pnas.84.5.1417","volume":"84","author":"GA Higgs","year":"1987","unstructured":"Higgs GA, Salmon JA, Henderson B, Vane JR (1987) Pharmacokinetics of aspirin and salicylate in relation to inhibition of arachidonate cyclooxygenase and antiinflammatory activity. Proc Natl Acad Sci USA 84(5):1417\u20131420. https:\/\/doi.org\/10.1073\/pnas.84.5.1417","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"3998_CR16","doi-asserted-by":"publisher","first-page":"381","DOI":"10.5811\/westjem.2011.4.2222","volume":"12","author":"SP Nordt","year":"2011","unstructured":"Nordt SP, Clark RF, Castillo EM, Guss DA (2011) Comparison of three aspirin formulations in human volunteers. western J Emerg Med 12(4):381\u2013385. https:\/\/doi.org\/10.5811\/westjem.2011.4.2222","journal-title":"western J Emerg Med"},{"issue":"2","key":"3998_CR17","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"B Ibanez","year":"2018","unstructured":"Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimsky P, Group ESCSD (2018) 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 39(2):119\u2013177. https:\/\/doi.org\/10.1093\/eurheartj\/ehx393","journal-title":"Eur Heart J"},{"issue":"6","key":"3998_CR18","doi-asserted-by":"publisher","first-page":"433","DOI":"10.2165\/00003088-199528060-00001","volume":"28","author":"F Bochner","year":"1995","unstructured":"Bochner F, Lloyd JV (1995) Aspirin for Myocardial Infarction. Clin Pharmacokinet 28(6):433\u2013438. https:\/\/doi.org\/10.2165\/00003088-199528060-00001","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"3998_CR19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1161\/01.STR.16.1.5","volume":"16","author":"BB Weksler","year":"1985","unstructured":"Weksler BB, Kent JL, Rudolph D, Scherer PB, Levy DE (1985) Effects of low dose aspirin on platelet function in patients with recent cerebral ischemia. Stroke 16(1):5\u20139. https:\/\/doi.org\/10.1161\/01.Str.16.1.5","journal-title":"Stroke"},{"issue":"19","key":"3998_CR20","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1093\/eurheartj\/ehae128","volume":"45","author":"S De Grimaldi","year":"2024","unstructured":"Grimaldi S, Migliorini P, Puxeddu I, Rossini R, De Caterina R (2024) Aspirin hypersensitivity: a practical guide for cardiologists. Eur Heart J 45(19):1716\u20131726. https:\/\/doi.org\/10.1093\/eurheartj\/ehae128","journal-title":"Eur Heart J"},{"key":"3998_CR21","doi-asserted-by":"publisher","unstructured":"Ramanuja S, Breall JA, Kalaria VG (2004) Approach to Aspirin Allergy in Cardiovascular Patients. Circulation 110(1). https:\/\/doi.org\/10.1161\/01.Cir.0000134306.28561.2a","DOI":"10.1161\/01.Cir.0000134306.28561.2a"},{"issue":"2","key":"3998_CR22","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.anai.2013.11.020","volume":"112","author":"KL McMullan","year":"2014","unstructured":"McMullan KL (2014) Aspirin allergy in patients with myocardial infarction: the allergist\u2019s role. Ann Allergy Asthma Immunol 112(2):90\u201393. https:\/\/doi.org\/10.1016\/j.anai.2013.11.020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"18","key":"3998_CR23","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1016\/j.jacc.2024.05.084","volume":"84","author":"M Galli","year":"2024","unstructured":"Galli M, Cortellini G, Occhipinti G, Rossini R, Romano A, Angiolillo DJ (2024) Aspirin Hypersensitivity in Patients With Atherosclerotic Cardiovascular Disease. J Am Coll Cardiol 84(18):1748\u20131766. https:\/\/doi.org\/10.1016\/j.jacc.2024.05.084","journal-title":"J Am Coll Cardiol"},{"key":"3998_CR24","doi-asserted-by":"publisher","unstructured":"Rao SV, O\u2019Donoghue ML, Ruel M, Rab T, Tamis-Holland JE, Alexander JH, Baber U, Baker H, Cohen MG, Cruz-Ruiz M, Davis LL, de Lemos JA, DeWald TA, Elgendy IY, Feldman DN, Goyal A, Isiadinso I, Menon V, Morrow DA, Mukherjee D, Platz E, Promes SB, Sandner S, Sandoval Y, Schunder R, Shah B, Stopyra JP, Talbot AW, Taub PR, Williams MS (2025) 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 151(13). https:\/\/doi.org\/10.1161\/cir.0000000000001309","DOI":"10.1161\/cir.0000000000001309"},{"key":"3998_CR25","doi-asserted-by":"publisher","unstructured":"Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Jr., Ganiats TG, Holmes DR, Jr., Jaffe AS, Jneid H, Kelly RF, Kontos MC, Levine GN, Liebson PR, Mukherjee D, Peterson ED, Sabatine MS, Smalling RW, Zieman SJ (2014) 2014 AHA\/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 64 (24): e139-e228 https:\/\/doi.org\/10.1016\/j.jacc.2014.09.017","DOI":"10.1016\/j.jacc.2014.09.017"},{"key":"3998_CR26","doi-asserted-by":"publisher","unstructured":"O\u2019Gara PT, Kushner FG, Ascheim DD, Casey DE, Jr., Chung MK, de Lemos JA, Ettinger SM, Fang JC, Fesmire FM, Franklin BA, Granger CB, Krumholz HM, Linderbaum JA, Morrow DA, Newby LK, Ornato JP, Ou N, Radford MJ, Tamis-Holland JE, Tommaso CL, Tracy CM, Woo YJ, Zhao DX (2013) 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology 61 (4): e78-e140 https:\/\/doi.org\/10.1016\/j.jacc.2012.11.019","DOI":"10.1016\/j.jacc.2012.11.019"},{"key":"3998_CR27","doi-asserted-by":"publisher","unstructured":"Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S (2015) 2015 ESC Guidelines for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-segment Elevation. Revista espanola de cardiologia 68 (12): 1125 https:\/\/doi.org\/10.1016\/j.rec.2015.10.009","DOI":"10.1016\/j.rec.2015.10.009"},{"issue":"38","key":"3998_CR28","doi-asserted-by":"publisher","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","volume":"44","author":"RA El Byrne","year":"2023","unstructured":"Byrne RA, Rossello X, Coughlan JJ, Barbato E, Berry C, Chieffo A, Claeys MJ, Dan G-A, Dweck MR, Galbraith M, Gilard M, Hinterbuchner L, Jankowska EA, J\u00fcni P, Kimura T, Kunadian V, Leosdottir M, Lorusso R, Pedretti RFE, Rigopoulos AG, Rubini Gimenez M, Thiele H, Vranckx P, Wassmann S, Wenger NK, Ibanez B, Halvorsen S, James S, Abdelhamid M, Aboyans V, Marsan NA, Antoniou S, Asteggiano R, B\u00e4ck M, Capodanno D, Casado-Arroyo R, Cassese S, \u010celutkien\u0117 J, Cikes M, Collet J-P, Ducrocq G, Falk V, Fauchier L, Geisler T, Gorog DA, Holmvang L, Jaarsma T, Jones HW, K\u00f8ber L, Koskinas KC, Kotecha D, Krychtiuk KA, Landmesser U, Lazaros G, Lewis BS, Lindahl B, Linhart A, L\u00f8chen M-L, Mamas MA, McEvoy JW, Mihaylova B, Mindham R, Mueller C, Neubeck L, Niebauer J, Nielsen JC, Niessner A, Paradies V, Pasquet AA, Petersen SE, Prescott E, Rakisheva A, Rocca B, Rosano GMC, Sade LE, Schiele F, Siller-Matula JM, Sticherling C, Storey RF, Thielmann M, Vrints C, Windecker S, Wiseth R, Witkowski A, El Amine Bouzid M, Hayrapetyan H, Metzler B, Lancellotti P, Bajri\u0107 M, Karamfiloff K, Mitsis A, Ostadal P, S\u00f8rensen R, Elwasify T, Marandi T, Ry\u00f6di E, Collet J-P, Chukhrukidze A, Mehilli J, Davlouros P, Becker D, Gu\u00f0mundsd\u00f3ttir IJ, Crowley J, Abramowitz Y, Indolfi C, Sakhov O, Elezi S, Beishenkulov M, Erglis A, Moussallem N, Benlamin H, Dobilien\u0117 O, Degrell P, Balbi MM, Grosu A, Lakhal Z, ten Berg J, Pejkov H, Angel K, Witkowski A, De Sousa Almeida M, Chioncel O, Bertelli L, Stojkovic S, Studen\u010dan M, Rad\u0161el P, Ferreiro JL, Ravn-Fischer A, R\u00e4ber L, Marjeh MYB, Hassine M, Yildirir A, Parkhomenko A, Banning AP, Prescott E, James S, Arbelo E, Baigent C, Borger MA, Buccheri S, Ibanez B, K\u00f8ber L, Koskinas KC, McEvoy JW, Mihaylova B, Mindham R, Neubeck L, Nielsen JC, Pasquet AA, Rakisheva A, Rocca B, Rossello X, Vaartjes I, Vrints C, Witkowski A, Zeppenfeld K (2023) 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 44(38):3720\u20133826. https:\/\/doi.org\/10.1093\/eurheartj\/ehad191","journal-title":"Eur Heart J"},{"key":"3998_CR29","doi-asserted-by":"publisher","unstructured":"Virani SS, Newby LK, Arnold SV, Bittner V, Brewer LC, Demeter SH, Dixon DL, Fearon WF, Hess B, Johnson HM, Kazi DS, Kolte D, Kumbhani DJ, LoFaso J, Mahtta D, Mark DB, Minissian M, Navar AM, Patel AR, Piano MR, Rodriguez F, Talbot AW, Taqueti VR, Thomas RJ, van Diepen S, Wiggins B, Williams MS (2023) 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation 148 (9) https:\/\/doi.org\/10.1161\/cir.0000000000001168","DOI":"10.1161\/cir.0000000000001168"},{"key":"3998_CR30","doi-asserted-by":"publisher","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, Banning AP, Budaj A, Buechel RR, Chiariello GA, Chieffo A, Christodorescu RM, Deaton C, Doenst T, Jones HW, Kunadian V, Mehilli J, Milojevic M, Piek JJ, Pugliese F, Rubboli A, Semb AG, Senior R, ten Berg JM, Van Belle E, Van Craenenbroeck EM, Vidal-Perez R, Winther S, Borger M, Gudmundsd\u00f3ttir IJ, Knuuti J, Ahrens I, B\u00f6hm M, Buccheri S, Capodanno D, Christiansen EH, Collet J-P, Dickstein K, Eek C, Falk V, Henriksen PA, Ibanez B, James S, Kedev S, K\u00f8ber L, Kyriakou M, Magavern EF, McInerney A, McEvoy JW, Mersha CO, Mihaylova B, Mindham R, Neubeck L, Neumann F-J, Nielsen JC, Paolisso P, Paradies V, Pasquet AA, Piepoli M, Prescott E, Rakisheva A, Rocca B, Ruel M, Sandner S, Saraste A, Szummer K, Vaartjes I, Wijns W, Windecker S, Witkowsky A, Zdrakovic M, Zeppenfeld K, Shuka N, Bouraghda MA, Hayrapetyan HG, Reinstadler SJ, Musayev O, De Pauw M, Ku\u0161ljugi\u0107 Z, Gelev V, Skoric B, Karakyriou M, Kovarnik T, Nielsen LH, Abdel-Aziz IS, Ainla T, Porela P, Benamer H, Nadaraia K, Richardt G, Papafaklis MI, Becker D, Gudmundsd\u00f3ttir IJ, Wolak A, Riccio C, Zholdin BK, Elezi S, Abilova S, Mintale I, Allam B, Badarien\u0117 J, Pereira B, Dingli P, Revenco V, Bulatovic N, Benouna EGM, Dedic A, Mitevska I, Angel K, Bryniarski K, Luz AMC, Popescu BA, Bertelli L, Beleslin BD, Hudec M, Fras Z, Freixa-Pamias R, Holm A, Jeger R, Marjeh MYB, Hammami R, Aytekin V, Nesukay EG, Swanson N, Shek AB (2024) 2024 ESC Guidelines for the management of chronic coronary syndromes. European Heart Journal 45 (36): 3415\u20133537 https:\/\/doi.org\/10.1093\/eurheartj\/ehae177","DOI":"10.1093\/eurheartj\/ehae177"},{"key":"3998_CR31","doi-asserted-by":"publisher","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, Kamel H, Kernan WN, Kittner SJ, Leira EC, Lennon O, Meschia JF, Nguyen TN, Pollak PM, Santangeli P, Sharrief AZ, Smith SC, Turan TN, Williams LS (2021) 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association\/American Stroke Association. Stroke 52 (7) https:\/\/doi.org\/10.1161\/str.0000000000000375","DOI":"10.1161\/str.0000000000000375"},{"key":"3998_CR32","doi-asserted-by":"publisher","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL (2019) Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association\/American Stroke Association. Stroke 50 (12) https:\/\/doi.org\/10.1161\/str.0000000000000211","DOI":"10.1161\/str.0000000000000211"},{"issue":"15","key":"3998_CR33","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.jacc.2023.07.025","volume":"82","author":"A Greco","year":"2023","unstructured":"Greco A, Occhipinti G, Giacoppo D, Agnello F, Laudani C, Spagnolo M, Mauro MS, Rochira C, Finocchiaro S, Mazzone PM, Faro DC, Landolina D, Ammirabile N, Imbesi A, Raffo C, Capodanno D (2023) Antithrombotic Therapy for Primary and Secondary Prevention of Ischemic Stroke. J Am Coll Cardiol 82(15):1538\u20131557. https:\/\/doi.org\/10.1016\/j.jacc.2023.07.025","journal-title":"J Am Coll Cardiol"},{"key":"3998_CR34","doi-asserted-by":"publisher","unstructured":"Gerhard-Herman MD, Gornik HL, Barrett C, Barshes NR, Corriere MA, Drachman DE, Fleisher LA, Fowkes FGR, Hamburg NM, Kinlay S, Lookstein R, Misra S, Mureebe L, Olin JW, Patel RAG, Regensteiner JG, Schanzer A, Shishehbor MH, Stewart KJ, Treat-Jacobson D, Walsh ME (2017) 2016 AHA\/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Journal of the American College of Cardiology 69 (11): e71-e126 https:\/\/doi.org\/10.1016\/j.jacc.2016.11.007","DOI":"10.1016\/j.jacc.2016.11.007"},{"key":"3998_CR35","doi-asserted-by":"publisher","unstructured":"Society for Vascular Surgery Lower Extremity Guidelines Writing G, Conte MS, Pomposelli FB, Clair DG, Geraghty PJ, McKinsey JF, Mills JL, Moneta GL, Murad MH, Powell RJ, Reed AB, Schanzer A, Sidawy AN, Society for Vascular S (2015) Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. Journal of vascular surgery 61 (3 Suppl): 2S-41S https:\/\/doi.org\/10.1016\/j.jvs.2014.12.009","DOI":"10.1016\/j.jvs.2014.12.009"},{"key":"3998_CR36","doi-asserted-by":"publisher","unstructured":"Obara H, Matsubara K, Kitagawa Y (2018) Acute Limb Ischemia. Annals of vascular diseases 11. 4 443\u2013448. https:\/\/doi.org\/10.3400\/avd.ra.18-00074","DOI":"10.3400\/avd.ra.18-00074"},{"issue":"24","key":"3998_CR37","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1182\/bloodadvances.2024014220","volume":"8","author":"N Chipalkatti","year":"2024","unstructured":"Chipalkatti N, Barnes GD, Bashaw L, Davie A, Griggs JJ, Harrod M, Kurlander JE, Medaugh C, Packard R, Powell C, Sood S, Spranger E, Vordenberg SE, Schaefer JK (2024) Guideline concordance of aspirin use for primary prevention in adult outpatients. Blood Adv 8(24):6207\u20136214. https:\/\/doi.org\/10.1182\/bloodadvances.2024014220","journal-title":"Blood Adv"},{"issue":"4","key":"3998_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1302\/2058-5241.3.170018","volume":"3","author":"DA Flevas","year":"2018","unstructured":"Flevas DA, Megaloikonomos PD, Dimopoulos L, Mitsiokapa E, Koulouvaris P, Mavrogenis AF (2018) Thromboembolism prophylaxis in orthopaedics: an update. EFORT open reviews 3(4):136\u2013148. https:\/\/doi.org\/10.1302\/2058-5241.3.170018","journal-title":"EFORT open reviews"},{"issue":"5","key":"3998_CR39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1002\/pd.5645","volume":"40","author":"L Loussert","year":"2020","unstructured":"Loussert L, Vidal F, Parant O, Hamdi SM, Vayssiere C, Guerby P (2020) Aspirin for prevention of preeclampsia and fetal growth restriction. Prenat Diagn 40(5):519\u2013527. https:\/\/doi.org\/10.1002\/pd.5645","journal-title":"Prenat Diagn"},{"key":"3998_CR40","doi-asserted-by":"publisher","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, Kobayashi T, Wu M-H, Saji TT, Pahl E (2017) Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association. Circulation 135 (17) DOI 10.1161\/cir.0000000000000484 https:\/\/doi.org\/10.1161\/cir.0000000000000484","DOI":"10.1161\/cir.0000000000000484"},{"key":"3998_CR41","doi-asserted-by":"publisher","unstructured":"Elias MD (2025) Kawasaki Disease and Anti-Inflammatory Doses of Aspirin\u2014A Complicated Relationship. JAMA Network Open 8 (4) https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.3073","DOI":"10.1001\/jamanetworkopen.2025.3073"},{"issue":"6","key":"3998_CR42","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.3324\/haematol.2022.281388","volume":"108","author":"M Cattaneo","year":"2023","unstructured":"Cattaneo M (2023) Aspirin in essential thrombocythemia. For whom? What formulation? What regimen? Haematol 108(6):1487\u20131499. https:\/\/doi.org\/10.3324\/haematol.2022.281388","journal-title":"What regimen? Haematol"},{"key":"3998_CR43","doi-asserted-by":"publisher","unstructured":"Krishnan K, Nguyen TN, Appleton JP, Law ZK, Caulfied M, Cabrera CP, Lenthall R, Hewson D, England T, McConachie N, Dhillon P, Malik L, Podlasek A, Smith CJ, Dawson J, Robinson TG, Sprigg N, James MA, White P, Desborough MJR, Hermans J, Bath PM (2023) Antiplatelet Resistance: A Review of Concepts, Mechanisms, and Implications for Management in Acute Ischemic Stroke and Transient Ischemic Attack. Stroke: Vascular and Interventional Neurology 3 (3) https:\/\/doi.org\/10.1161\/svin.122.000576","DOI":"10.1161\/svin.122.000576"},{"issue":"6","key":"3998_CR44","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jacc.2016.11.050","volume":"69","author":"DL Bhatt 3rd","year":"2017","unstructured":"Bhatt DL, Grosser T, Dong JF, Logan D, Jeske W, Angiolillo DJ, Frelinger AL 3rd, Lei L, Liang J, Moore JE, Cryer B, Marathi U (2017) Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus. J Am Coll Cardiol 69(6):603\u2013612. https:\/\/doi.org\/10.1016\/j.jacc.2016.11.050","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"3998_CR45","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/BF02849852","volume":"20","author":"W Kusche","year":"2003","unstructured":"Kusche W, Paxinos R, Haselmann J, Schwantes U, Breddin HK (2003) Acetylsalicylic acid tablets with glycine improve long-term tolerability in antiplatelet drug therapy: results of a noninterventional trial. Adv therapy 20(5):237\u2013245","journal-title":"Adv therapy"},{"issue":"7","key":"3998_CR46","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/j.jacc.2005.06.058","volume":"46","author":"AO Maree","year":"2005","unstructured":"Maree AO, Curtin RJ, Dooley M, Conroy RM, Crean P, Cox D, Fitzgerald DJ (2005) Platelet Response to Low-Dose Enteric-Coated Aspirin in Patients With Stable Cardiovascular Disease. J Am Coll Cardiol 46(7):1258\u20131263. https:\/\/doi.org\/10.1016\/j.jacc.2005.06.058","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"3998_CR47","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jacc.2016.11.050","volume":"69","author":"DL Bhatt","year":"2017","unstructured":"Bhatt DL, Grosser T, Dong J-f, Logan D, Jeske W, Angiolillo DJ, Frelinger AL, Lei L, Liang J, Moore JE, Cryer B, Marathi U (2017) Enteric Coating and Aspirin Nonresponsiveness in Patients With Type 2 Diabetes Mellitus. J Am Coll Cardiol 69(6):603\u2013612. https:\/\/doi.org\/10.1016\/j.jacc.2016.11.050","journal-title":"J Am Coll Cardiol"},{"key":"3998_CR48","doi-asserted-by":"publisher","unstructured":"Sleem A, Effron MB, Stebbins A, Wruck LM, Marquis-Gravel G, Mu\u00f1oz D, Re RN, Gupta K, Pepine CJ, Jain SK, Girotra S, Whittle J, Benziger CP, Farrehi PM, Knowlton KU, Polonsky TS, Roe MT, Rothman RL, Harrington RA, Jones WS, Hernandez AF (2023) Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease. JAMA Cardiol 8(11). https:\/\/doi.org\/10.1001\/jamacardio.2023.3364","DOI":"10.1001\/jamacardio.2023.3364"},{"key":"3998_CR49","doi-asserted-by":"publisher","unstructured":"Krauss E, Cronin M, Dengler N, Segal A (2020) Interaction Between Low-Dose Aspirin and Nonsteroidal Anti-Inflammatory Drugs Can Compromise Aspirin\u2019s Efficacy in Preventing Venous Thrombosis Following Total Joint Arthroplasty. Clinical and Applied Thrombosis\/Hemostasis 26 https:\/\/doi.org\/10.1177\/1076029620920373","DOI":"10.1177\/1076029620920373"},{"key":"3998_CR50","doi-asserted-by":"publisher","unstructured":"Wei J, Zeng C, Lane NE, Li X, Lei G, Zhang Y (2023) Interactions of Nonsteroidal Antiinflammatory Drugs and Aspirin and Risk of Cardiovascular Disease in Patients With Osteoarthritis. American Journal of Epidemiology 192 (9): 1432\u20131448 https:\/\/doi.org\/10.1093\/aje\/kwad094","DOI":"10.1093\/aje\/kwad094"},{"issue":"5","key":"3998_CR51","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.cpcardiol.2017.01.006","volume":"42","author":"CJ Lavie","year":"2017","unstructured":"Lavie CJ, Howden CW, Scheiman J, Tursi J (2017) Upper Gastrointestinal Toxicity Associated With Long-Term Aspirin Therapy: Consequences and Prevention. Curr Probl Cardiol 42(5):146\u2013164. https:\/\/doi.org\/10.1016\/j.cpcardiol.2017.01.006","journal-title":"Curr Probl Cardiol"},{"key":"3998_CR52","doi-asserted-by":"publisher","unstructured":"Clerici B, Cattaneo M (2023) Pharmacological Efficacy and Gastrointestinal Safety of Different Aspirin Formulations for Cardiovascular Prevention: A Narrative Review. Journal of Cardiovascular Development and Disease 10 (4) https:\/\/doi.org\/10.3390\/jcdd10040137","DOI":"10.3390\/jcdd10040137"},{"issue":"1","key":"3998_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1093\/ehjcvp\/pvv038","volume":"2","author":"M Vaduganathan","year":"2016","unstructured":"Vaduganathan M, Bhatt DL (2016) Aspirin and proton-pump inhibitors: interpreting the interplay. Eur Heart J - Cardiovasc Pharmacotherapy 2(1):20\u201322. https:\/\/doi.org\/10.1093\/ehjcvp\/pvv038","journal-title":"Eur Heart J - Cardiovasc Pharmacotherapy"},{"issue":"9","key":"3998_CR54","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1517\/17425255.2012.711318","volume":"8","author":"M W\u00fcrtz","year":"2012","unstructured":"W\u00fcrtz M, Grove EL (2012) Combining aspirin and proton pump inhibitors: for whom the warning bell tolls? Expert Opin Drug Metab Toxicol 8(9):1051\u20131055. https:\/\/doi.org\/10.1517\/17425255.2012.711318","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"20","key":"3998_CR55","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1056\/NEJMoa1007964","volume":"363","author":"DL Bhatt","year":"2010","unstructured":"Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP (2010) Clopidogrel with or without Omeprazole in Coronary Artery Disease. N Engl J Med 363(20):1909\u20131917. https:\/\/doi.org\/10.1056\/NEJMoa1007964","journal-title":"N Engl J Med"},{"key":"3998_CR56","doi-asserted-by":"publisher","unstructured":"Charlot M, Grove EL, Hansen PR, Olesen JB, Ahlehoff O, Selmer C, Lindhardsen J, Madsen JK, Kober L, Torp-Pedersen C, Gislason GH (2011) Proton pump inhibitor use and risk of adverse cardiovascular events in aspirin treated patients with first time myocardial infarction: nationwide propensity score matched study. Bmj 342 (may11 1): d2690-d2690 https:\/\/doi.org\/10.1136\/bmj.d2690","DOI":"10.1136\/bmj.d2690"},{"key":"3998_CR57","doi-asserted-by":"crossref","unstructured":"Capodanno D, Angiolillo DJ (2023) Personalised antiplatelet therapies for coronary artery disease: what the future holds. European Heart Journal 44 (32): 3059\u20133072 DOI 10.1093\/eurheartj\/ehad362","DOI":"10.1093\/eurheartj\/ehad362"},{"key":"3998_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2022.12.008","volume":"110","author":"P De Sabouret","year":"2023","unstructured":"Sabouret P, Spadafora L, Fischman D, Ullah W, Zeitouni M, Gulati M, De Rosa S, Savage MP, Costabel JP, Banach M, Biondi-Zoccai G, Galli M (2023) De-escalation of antiplatelet therapy in patients with coronary artery disease: Time to change our strategy? Eur J Intern Med 110:1\u20139. https:\/\/doi.org\/10.1016\/j.ejim.2022.12.008","journal-title":"Eur J Intern Med"},{"issue":"21","key":"3998_CR59","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","volume":"381","author":"R Mehran","year":"2019","unstructured":"Mehran R, Baber U, Sharma SK, Cohen DJ, Angiolillo DJ, Briguori C, Cha JY, Collier T, Dangas G, Dudek D, D\u017eav\u00edk V, Escaned J, Gil R, Gurbel P, Hamm CW, Henry T, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff M, Kunadian V, Marx SO, Mehta SR, Moliterno D, Ohman EM, Oldroyd K, Sardella G, Sartori S, Shlofmitz R, Steg PG, Weisz G, Witzenbichler B, Han Y-l, Pocock S, Gibson CM (2019) Ticagrelor with or without Aspirin in High-Risk Patients after PCI. N Engl J Med 381(21):2032\u20132042. https:\/\/doi.org\/10.1056\/NEJMoa1908419","journal-title":"N Engl J Med"},{"key":"3998_CR60","doi-asserted-by":"crossref","unstructured":"Vranckx P, Valgimigli M, J\u00fcni P, Hamm C, Steg PG, Heg D, van Es GA, McFadden EP, Onuma Y, van Meijeren C, Chichareon P, Benit E, M\u00f6llmann H, Janssens L, Ferrario M, Moschovitis A, Zurakowski A, Dominici M, Van Geuns RJ, Huber K, Slagboom T, Serruys PW, Windecker S, Abdellaoui M, Adlam D, Akin I, Albarran Gonzalez-Trevilla A, Almeida M, Alves Lemos Neto P, Aminian A, Anderson R, Andreae R, Angioi M, Asano T, Barbato E, Barlis P, Barraud P, Benit E, Bertrand O, Beygui F, Bolognese L, Botelho R, Bouwman C, Bressers M, Brunel P, Buszman P, Buysschaert I, Canas da Silva P, Carrie D, Cequier A, Chichareon P, Chin Chang C, Chowdhary S, Collet C, Colombo A, Cotton J, Cruz Ferreira R, Curello S, Curzen N, de Bot J, de Vreede T, Delle Karth G, Dijksma L, Dominici M, \u00c9des I, Eeckhout E, Eitel I, Faluk\u00f6zy J, Fath-Ordoubadi F, Ferrario M, Fontos G, Francisco Diaz J, Freitas Quintella E, Frey B, Friedrich G, Galasko G, Galuszka G, Gama Ribeiro V, Garg S, Gargiulo G, Geisler T, Gelev V, Ghandilyan A, Goicolea J, Gori T, Gragnano F, Guimar\u00e3es A, Hamm C, Haude M, Heg D, Heijke P, Hern\u00e1ndez Antolin RA, Hildick-Smith D, Hillen D, Hoekman I, Hofma S, Holmvang L, Hoole S, Horv\u00e1th I, Huber K, Hugense A, Ibrahim K, I\u00f1iguez A, Isaaz K, Jambrik Z, Janssens L, Jasionowicz P, Jonk J, Jung W, J\u00fcni P, Katagiri Y, Kogame N, Koh TH, Koning R, Konteva M, K\u0151szegi Z, Krackhardt F, Kreuger Y, Kukreja N, Ladan B, Lantelme P, Leandro S, Leibundgut G, Liebetrau C, Lindeboom W, Macaya Miguel C, Mach F, Magro M, Maillard L, Manavifar N, Mauri L, McFadden E, Merkely B, Miyazaki Y, M\u0142odziankowski A, Moccetti T, Modolo R, M\u00f6llman H, Morelle J-F, Moschovitis A, Munndt Ottesen M, Muurling M, Naber CK, Neumann F-J, Oldroyd K, Ong P, Onuma Y, Palsrok S, Petrov I, Plante S, Prokopczuk J, Rademaker-Havinga T, Raffel C, Rensing B, Roffi M, Royaards K-J, Sabate M, Sch\u00e4chinger V, Seidler T, Serra Pe\u00f1aranda A, Serruys P, Sikarulidze L, Slagboom T, Soliman OI, Sousa A, Spitzer E, Stables R, Steg G, Steinwender C, Subkovas E, Suryapranata H, Takahashi K, Talwar S, Teiger E, ter Weele A, Teurlings E, Thury A, Tijssen J, Tonev G, Trendafilova-Lazarova D, Tumscitz C, Umans V, Ungi I, Valkov V, van der Harst P, van Geuns RJ, van Meijeren C, Vassilev D, Velchev V, Velthuizen E, Verheugt F, Vlcek N, vom Dahl J, Vrolix M, Walsh S, Werner N, Windecker S, Witsenburg M, Zaman A, \u017bmudka K, Zrenner B, Zurakowski A, Zweiker R (2018) Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial. The Lancet 392 (10151): 940\u2013949 DOI 10.1016\/s0140-6736(18)31858-0","DOI":"10.1016\/S0140-6736(18)31858-0"},{"key":"3998_CR61","doi-asserted-by":"publisher","unstructured":"Kim B-K, Hong S-J, Cho Y-H, Yun KH, Kim YH, Suh Y, Cho JY, Her A-Y, Cho S, Jeon DW, Yoo S-Y, Cho D-K, Hong B-K, Kwon H, Ahn C-M, Shin D-H, Nam C-M, Kim J-S, Ko Y-G, Choi D, Hong M-K, Jang Y (2020) Effect of Ticagrelor Monotherapy vs Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events in Patients With Acute Coronary Syndrome. Jama 323 (23) https:\/\/doi.org\/10.1001\/jama.2020.7580","DOI":"10.1001\/jama.2020.7580"},{"key":"3998_CR62","doi-asserted-by":"publisher","unstructured":"Hahn J-Y, Song YB, Oh J-H, Chun WJ, Park YH, Jang WJ, Im E-S, Jeong J-O, Cho BR, Oh SK, Yun KH, Cho D-K, Lee J-Y, Koh Y-Y, Bae J-W, Choi JW, Lee WS, Yoon HJ, Lee SU, Cho JH, Choi WG, Rha S-W, Lee JM, Park TK, Yang JH, Choi J-H, Choi S-H, Lee SH, Gwon H-C (2019) Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention. Jama 321 (24) https:\/\/doi.org\/10.1001\/jama.2019.8146","DOI":"10.1001\/jama.2019.8146"},{"key":"3998_CR63","doi-asserted-by":"publisher","unstructured":"Jang Y, Park S-D, Lee JP, Choi SH, Kong MG, Won YS, Kim M, Lee KH, Han SH, Kwon SW, Suh J, Kang WC (2025) One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial. EuroIntervention 21 (14): e796-e809 https:\/\/doi.org\/10.4244\/eij-d-25-00331","DOI":"10.4244\/eij-d-25-00331"},{"key":"3998_CR64","doi-asserted-by":"publisher","unstructured":"Watanabe H, Domei T, Morimoto T, Natsuaki M, Shiomi H, Toyota T, Ohya M, Suwa S, Takagi K, Nanasato M, Hata Y, Yagi M, Suematsu N, Yokomatsu T, Takamisawa I, Doi M, Noda T, Okayama H, Seino Y, Tada T, Sakamoto H, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Hanaoka KI, Morino Y, Kozuma K, Kadota K, Furukawa Y, Nakagawa Y, Kimura T (2019) Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI. Jama 321 (24) https:\/\/doi.org\/10.1001\/jama.2019.8145","DOI":"10.1001\/jama.2019.8145"},{"key":"3998_CR65","doi-asserted-by":"publisher","unstructured":"Guimar\u00e3es PO, Franken M, Tavares CAM, Antunes MO, Silveira FS, Andrade PB, Bergo RR, Joaquim RM, Tinoco de Paula JE, Nascimento BR, Pitta FG, Arruda JA, Serpa RG, Ohe LN, Mangione FM, Furtado RHM, Ferreira E, Sampaio FBA, T. do Nascimento C, Genelhu LOO, Bezerra CG, Sarmento-Leite R, Maia LN, Oliveira FRA, Wainstein MV, Dall\u2019Orto FTC, Monfardini F, Assis SRL, Nicolau JC, Sposito AC, Lopes RD, Onuma Y, Valgimigli M, Angiolillo DJ, Serruys PWJC, Berwanger O, Bacal F, Lemos PA (2025) Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes. New England Journal of Medicine https:\/\/doi.org\/10.1056\/NEJMoa2507980","DOI":"10.1056\/NEJMoa2507980"},{"key":"3998_CR66","doi-asserted-by":"publisher","unstructured":"Banerjee S, Angiolillo DJ, Boden WE, Murphy JG, Khalili H, Hasan AA, Harrington RA, Rao SV (2017) Use of Antiplatelet Therapy\/DAPT for Post-PCI Patients Undergoing Noncardiac Surgery. Journal of the American College of Cardiology 69 (14): 1861\u20131870 https:\/\/doi.org\/10.1016\/j.jacc.2017.02.012","DOI":"10.1016\/j.jacc.2017.02.012"},{"key":"3998_CR67","doi-asserted-by":"publisher","unstructured":"Swan D, Turner R, Douketis J, Thachil J (2024) How to undertake procedures while on antiplatelet agents: a hematologist\u2019s view. Research and Practice in Thrombosis and Haemostasis 8 (6) https:\/\/doi.org\/10.1016\/j.rpth.2024.102539","DOI":"10.1016\/j.rpth.2024.102539"},{"key":"3998_CR68","doi-asserted-by":"publisher","unstructured":"Gupta AK, Zaka A, Lombardo A, Tsimiklis J, Stretton B, Kovoor JG, Bacchi S, Ramponi F, Chan JCY, Thiagalingam A, Gould P, Sivagangabalan G, Zaman S, Chow C, Kovoor P, Smith JA, Bennetts JS, Maddern GJ (2025) Perioperative aspirin and coronary artery bypass graft surgery: An updated meta-analysis of randomized controlled trials. Surgery 180 DOI https:\/\/doi.org\/10.1016\/j.surg.2024.109003","DOI":"10.1016\/j.surg.2024.109003"},{"issue":"24","key":"3998_CR69","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1016\/j.jacc.2024.08.024","volume":"84","author":"D-Y Kang","year":"2024","unstructured":"Kang D-Y, Lee S-H, Lee S-W, Lee CH, Kim C, Jang J-Y, Mehta N, Oh J-H, Cho YR, Yoon KH, Ahn SG, Lee J-H, Cho D-K, Kim Y, Kim J, Cho GH, Lee K-S, Park H, Vural M, Lim Y-H, Park K-H, Lee B-K, Lee J-Y, Park H-W, Yoon Y-H, Lee J-H, Lee S-Y, Park KW, Kang J, Kim HK, Kang S-H, Park J-H, Choi I-C, Yu CS, Yun S-C, Park D-W, Hong M-K, Park S-J, Kim J-S, Ahn J-M, Ahn J-M, Park S-J, Park D-W, Kang D-Y, Yu CS, Choi I-C, Kim J-S, Hong M-K, Lee S-H, Lee S-W, Lee CH, Kim C, Jang J-Y, Mehta N, Oh J-H, Cho YR, Yoon KH, Ahn SG, Cho D-K, Kim Y, Kim J, Cho GH, Lee K-S, Park H, Vural M, Yilmaz I, Sahin I, Lim Y-H, Park K-H, Lee B-K, Lee J-Y, Park H-W, Yoon Y-H, Lee S-Y, Lee J-H, Lee J-H, Park K-W, Kang J, Kim HK, Kang S-H, Park J-H (2024) Aspirin Monotherapy vs No Antiplatelet Therapy in Stable Patients With Coronary Stents Undergoing Low-to-Intermediate Risk Noncardiac Surgery. J Am Coll Cardiol 84(24):2380\u20132389. https:\/\/doi.org\/10.1016\/j.jacc.2024.08.024","journal-title":"J Am Coll Cardiol"},{"key":"3998_CR70","doi-asserted-by":"publisher","unstructured":"Gonzalez-Correa JA, De La Cruz JP (2006) Triflusal: an antiplatelet drug with a neuroprotective effect? Cardiovascular drug reviews 24. 111\u201324. https:\/\/doi.org\/10.1111\/j.1527-3466.2006.00011.x","DOI":"10.1111\/j.1527-3466.2006.00011.x"},{"issue":"2","key":"3998_CR71","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0306-3623(92)90027-H","volume":"23","author":"JP de la Cruz","year":"1992","unstructured":"de la Cruz JP, Mata JM, de la Sanchez F (1992) Triflusal vs aspirin on the inhibition of human platelet and vascular cyclooxygenase. Gen Pharmacol 23(2):297\u2013300","journal-title":"Gen Pharmacol"},{"issue":"3","key":"3998_CR72","first-page":"199","volume":"50","author":"H Anninos","year":"2009","unstructured":"Anninos H, Andrikopoulos G, Pastromas S, Sakellariou D, Theodorakis G, Vardas P (2009) Triflusal: an old drug in modern antiplatelet therapy. Review of its action, use, safety and effectiveness. Hellenic J cardiology: HJC = Hellenike kardiologike epitheorese 50(3):199\u2013207","journal-title":"Hellenic J cardiology: HJC = Hellenike kardiologike epitheorese"},{"issue":"5","key":"3998_CR73","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1159\/000131083","volume":"25","author":"C Executive","year":"2008","unstructured":"European Stroke Organisation, Executive C, Committee ESOW (2008) Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 25(5):457\u2013507. https:\/\/doi.org\/10.1159\/000131083","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"3998_CR74","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1161\/01.Str.0000063141.24491.50","volume":"34","author":"J Mat\u00edas-Guiu","year":"2003","unstructured":"Mat\u00edas-Guiu J, Ferro JM, Alvarez-Sab\u00edn J, Torres F, Jim\u00e9nez MD, Lago A, Melo T (2003) Comparison of Triflusal and Aspirin for Prevention of Vascular Events in Patients After Cerebral Infarction. Stroke 34(4):840\u2013848.","journal-title":"Stroke"},{"issue":"6","key":"3998_CR75","doi-asserted-by":"publisher","first-page":"635","DOI":"10.2174\/1570161116666180605090520","volume":"17","author":"KI Kalantzi","year":"2019","unstructured":"Kalantzi KI, Ntalas IV, Chantzichristos VG, Tsoumani ME, Adamopoulos D, Asimakopoulos C, Bourdakis A, Darmanis P, Dimitriadou A, Gkiokas S, Ipeirotis K, Kitikidou K, Klonaris I, Kostaki A, Logothetis D, Mainas K, Mais T, Maragiannis A, Martiadou K, Mavronasos K, Michelongonas I, Mitropoulos D, Papadimitriou G, Papadopoulos A, Papaioakeim M, Sofillas K, Stabola S, Stefanakis E, Stergiou D, Thoma M, Zenetos A, Zisekas S, Goudevenos JA, Panagiotakos DB, Tselepis AD (2019) Comparison of Triflusal with Aspirin in the Secondary Prevention of Atherothrombotic Events; \u0391 Randomised Clinical Trial. Curr Vasc Pharmacol 17(6):635\u2013643.","journal-title":"Curr Vasc Pharmacol"},{"issue":"3","key":"3998_CR76","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000357662","volume":"37","author":"J Alvarez-Sab\u00edn","year":"2014","unstructured":"Alvarez-Sab\u00edn J, Quintana M, Santamarina E, Maisterra O (2014) Triflusal and Aspirin in the Secondary Prevention of Atherothrombotic Ischemic Stroke: A Very Long-Term Follow-Up. Cerebrovasc Dis 37(3):181\u2013187. https:\/\/doi.org\/10.1159\/000357662","journal-title":"Cerebrovasc Dis"},{"issue":"3","key":"3998_CR77","doi-asserted-by":"publisher","first-page":"356","DOI":"10.5853\/jos.2017.01249","volume":"19","author":"SW Han","year":"2017","unstructured":"Han SW, Kim YJ, Ahn SH, Seo WK, Yu S, Oh SH, Nam HS, Choi HY, Yoon SS, Kim SH, Lee JY, Lee JH, Hwang YH, Lee KO, Jung YH, Lee J, Sohn SI, Kim YN, Lee KA, Bushnell CD, Lee KY (2017) Effects of Triflusal and Clopidogrel on the Secondary Prevention of Stroke Based on Cytochrome P450 2C19 Genotyping. J stroke 19(3):356\u2013364. https:\/\/doi.org\/10.5853\/jos.2017.01249","journal-title":"J stroke"},{"key":"3998_CR78","doi-asserted-by":"publisher","unstructured":"Culebras A, Messe SR, Chaturvedi S, Kase CS, Gronseth G (2014) Summary of evidence-based guideline update: prevention of stroke in nonvalvular atrial fibrillation: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology 82 (8): 716\u2013724 https:\/\/doi.org\/10.1212\/WNL.0000000000000145","DOI":"10.1212\/WNL.0000000000000145"},{"key":"3998_CR79","doi-asserted-by":"publisher","unstructured":"Capodanno D, Ferreiro JL, Angiolillo DJ (2013) Antiplatelet therapy: new pharmacological agents and changing paradigms. J Thromb Haemost 11 Suppl 1: 316\u2013329 https:\/\/doi.org\/10.1111\/jth.12219","DOI":"10.1111\/jth.12219"},{"issue":"1","key":"3998_CR80","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1046\/j.1365-2044.2003.02960.x","volume":"58","author":"PC Kam","year":"2003","unstructured":"Kam PC, Nethery CM (2003) The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments. Anaesthesia 58(1):28\u201335","journal-title":"Anaesthesia"},{"issue":"15","key":"3998_CR81","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1161\/01.CIR.100.15.1667","volume":"100","author":"MJ Quinn","year":"1999","unstructured":"Quinn MJ, Fitzgerald DJ (1999) Ticlopidine and clopidogrel. Circulation 100(15):1667\u20131672","journal-title":"Circulation"},{"issue":"2","key":"3998_CR82","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/j.1538-7836.2011.04576.x","volume":"10","author":"A Smolenski","year":"2012","unstructured":"Smolenski A (2012) Novel roles of cAMP\/cGMP-dependent signaling in platelets. J Thromb Haemost 10(2):167\u2013176. https:\/\/doi.org\/10.1111\/j.1538-7836.2011.04576.x","journal-title":"J Thromb Haemost"},{"issue":"2","key":"3998_CR83","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.thromres.2014.04.027","volume":"134","author":"E Fuentes","year":"2014","unstructured":"Fuentes E, Palomo I (2014) Regulatory mechanisms of cAMP levels as a multiple target for antiplatelet activity and less bleeding risk. Thromb Res 134(2):221\u2013226. https:\/\/doi.org\/10.1016\/j.thromres.2014.04.027","journal-title":"Thromb Res"},{"issue":"1","key":"3998_CR84","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10557-019-06930-9","volume":"34","author":"X Li","year":"2020","unstructured":"Li X, Liu P, Xu Z, Sun D, Gu J, Miao Y, Zhang J, Cao X (2020) A Pharmacodynamic Study of CN-218, a Novel Antiplatelet and Antithrombotic Agent Primarily Targeting the P2Y12 Receptor. Cardiovasc Drugs Ther 34(1):15\u201323. https:\/\/doi.org\/10.1007\/s10557-019-06930-9","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"3998_CR85","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1160\/TH07-09-0555","volume":"99","author":"JA Jakubowski","year":"2008","unstructured":"Jakubowski JA, Payne CD, Li YG, Farid NA, Brandt JT, Small DS, Salazar DE, Winters KJ (2008) A comparison of the antiplatelet effects of prasugrel and high-dose clopidogrel as assessed by VASP-phosphorylation and light transmission aggregometry. Thromb Haemost 99(1):215\u2013222. https:\/\/doi.org\/10.1160\/TH07-09-0555","journal-title":"Thromb Haemost"},{"key":"3998_CR86","doi-asserted-by":"crossref","unstructured":"Nawarskas J, Newsome C, Anderson J, Ahmed B (2015) P2Y12 inhibitors for acute coronary syndromes: current perspectives. Research Reports in Clinical Cardiology.","DOI":"10.2147\/RRCC.S69478"},{"issue":"2","key":"3998_CR87","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2165\/00003495-199040020-00006","volume":"40","author":"D McTavish","year":"1990","unstructured":"McTavish D, Faulds D, Goa KL (1990) Ticlopidine. An updated review of its pharmacology and therapeutic use in platelet-dependent disorders. Drugs 40(2):238\u2013259.","journal-title":"Drugs"},{"key":"3998_CR88","doi-asserted-by":"publisher","first-page":"850028","DOI":"10.3389\/fcvm.2022.850028","volume":"9","author":"A Al-Abcha Jr.","year":"2022","unstructured":"Al-Abcha A, Radwan Y, Blais D, Mazzaferri EL Jr., Boudoulas KD, Essa EM, Gumina RJ (2022) Genotype-Guided Use of P2Y12 Inhibitors: A Review of Current State of the Art. Front Cardiovasc Med 9:850028. https:\/\/doi.org\/10.3389\/fcvm.2022.850028","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"3998_CR89","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","volume":"39","author":"M Valgimigli","year":"2018","unstructured":"Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Juni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN, Group ESCSD, Guidelines ESCCP, Societies ESCNC (2018) 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 39(3):213\u2013260. https:\/\/doi.org\/10.1093\/eurheartj\/ehx419","journal-title":"Eur Heart J"},{"issue":"3","key":"3998_CR90","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/rth2.12115","volume":"2","author":"T Gremmel III","year":"2018","unstructured":"Gremmel T, Michelson AD, Frelinger AL III, Bhatt DL (2018) Novel aspects of antiplatelet therapy in cardiovascular disease. Res Pract Thromb Haemost 2(3):439\u2013449.","journal-title":"Res Pract Thromb Haemost"},{"key":"3998_CR91","doi-asserted-by":"publisher","unstructured":"ten Cate H, Wong Y-S, Tsai C-F, Hsu Y-H, Ong C-T (2020) Efficacy of aspirin, clopidogrel, and ticlopidine in stroke prevention: A population-based case-cohort study in Taiwan. PLoS ONE 15(12). https:\/\/doi.org\/10.1371\/journal.pone.0242466","DOI":"10.1371\/journal.pone.0242466"},{"issue":"1","key":"3998_CR92","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1124\/dmd.113.053017","volume":"42","author":"MJ Kim","year":"2014","unstructured":"Kim MJ, Jeong ES, Park JS, Lee SJ, Ghim JL, Choi CS, Shin JG, Kim DH (2014) Multiple cytochrome P450 isoforms are involved in the generation of a pharmacologically active thiol metabolite, whereas paraoxonase 1 and carboxylesterase 1 catalyze the formation of a thiol metabolite isomer from ticlopidine. Drug Metab Dispos 42(1):141\u2013152. https:\/\/doi.org\/10.1124\/dmd.113.053017","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"3998_CR93","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1111\/bjh.12303","volume":"161","author":"CL Bennett","year":"2013","unstructured":"Bennett CL, Jacob S, Dunn BL, Georgantopoulos P, Zheng XL, Kwaan HC, McKoy JM, Magwood JS, Qureshi ZP, Bandarenko N, Winters JL, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Ablin RJ, Rock G, Matsumoto M, Fujimura Y (2013) Ticlopidine-associated ADAMTS13 activity deficient thrombotic thrombocytopenic purpura in 22 persons in Japan: a report from the Southern Network on Adverse Reactions (SONAR). Br J Haematol 161(6):896\u2013898.","journal-title":"Br J Haematol"},{"issue":"2","key":"3998_CR94","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40262-014-0230-6","volume":"54","author":"XL Jiang","year":"2015","unstructured":"Jiang XL, Samant S, Lesko LJ, Schmidt S (2015) Clinical pharmacokinetics and pharmacodynamics of clopidogrel. Clin Pharmacokinet 54(2):147\u2013166. https:\/\/doi.org\/10.1007\/s40262-014-0230-6","journal-title":"Clin Pharmacokinet"},{"issue":"26","key":"3998_CR95","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1056\/NEJMoa2309137","volume":"389","author":"Y Gao","year":"2023","unstructured":"Gao Y, Chen W, Pan Y, Jing J, Wang C, Johnston SC, Amarenco P, Bath PM, Jiang L, Yang Y, Wang T, Han S, Meng X, Lin J, Zhao X, Liu L, Zhao J, Li Y, Zang Y, Zhang S, Yang H, Yang J, Wang Y, Li D, Wang Y, Liu D, Kang G, Wang Y, Wang Y (2023) Dual Antiplatelet Treatment up to 72 Hours after Ischemic Stroke. N Engl J Med 389(26):2413\u20132424. https:\/\/doi.org\/10.1056\/NEJMoa2309137","journal-title":"N Engl J Med"},{"issue":"3","key":"3998_CR96","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1056\/NEJMoa1800410","volume":"379","author":"SC Johnston","year":"2018","unstructured":"Johnston SC, Easton JD, Farrant M, Barsan W, Conwit RA, Elm JJ, Kim AS, Lindblad AS, Palesch YY (2018) Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA. N Engl J Med 379(3):215\u2013225.","journal-title":"N Engl J Med"},{"key":"3998_CR97","doi-asserted-by":"crossref","unstructured":"Tscharre M, Mutschlechner D, Huber K, Gremmel T (2025) Antiplatelet therapy with clopidogrel versus aspirin in atherosclerotic cardiovascular disease: a systematic review and meta-analysis. Atherosclerosis 409.","DOI":"10.1016\/j.atherosclerosis.2025.120478"},{"key":"3998_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(25)01562-4","author":"M Valgimigli","year":"2025","unstructured":"Valgimigli M, Choi KH, Giacoppo D, Gragnano F, Kimura T, Watanabe H, Kim H-S, Kang J, Park KW, Pettersen A-\u00c5, Woodward M, Bhatt DL, Calabr\u00f2 P, Angiolillo DJ, Mehran R, Song YB, Hahn J-Y (2025) Clopidogrel versus aspirin for secondary prevention of coronary artery disease: a systematic review and individual patient data meta-analysis. Lancet.","journal-title":"Lancet"},{"issue":"5","key":"3998_CR99","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/cpt.2526","volume":"112","author":"CR Shuldiner Lee","year":"2022","unstructured":"Lee CR, Luzum JA, Sangkuhl K, Gammal RS, Sabatine MS, Stein Charles M, Kisor DF, Limdi NA, Lee YM, Scott SA, Hulot JS, Roden DM, Gaedigk A, Caudle KE, Klein TE, Johnson Julie A, Shuldiner Alan R (2022) Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2C19 Genotype and Clopidogrel Therapy: 2022 Update. Clin Pharmacol Ther 112(5):959\u2013967.","journal-title":"Clin Pharmacol Ther"},{"issue":"9","key":"3998_CR100","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1111\/jth.12342","volume":"11","author":"JP Lewis","year":"2013","unstructured":"Lewis JP, Stephens SH, Horenstein RB, O\u2019Connell JR, Ryan K, Peer CJ, Figg WD, Spencer SD, Pacanowski MA, Mitchell BD, Shuldiner AR (2013) The CYP2C19*17 variant is not independently associated with clopidogrel response. J Thromb Haemost 11(9):1640\u20131646.","journal-title":"J Thromb Haemost"},{"issue":"10486","key":"3998_CR101","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/s0140-6736(25)00449-0","volume":"405","author":"KH Choi","year":"2025","unstructured":"Choi KH, Park YH, Lee J-Y, Jeong J-O, Kim CJ, Yun KH, Lee HC, Chang K, Park M-W, Bae J-W, Doh J-H, Cho BR, Kim H-Y, Kim W, Kim U, Rha S-W, Hong YJ, Lee H-J, Ahn SG, Kim D-I, Cho JH, Her SH, Jeon DS, Han SH, Lee J-B, Lee CW, Kang D, Lee JM, Park TK, Yang JH, Lee S-Y, Choi S-H, Gwon H-C, Song YB, Hahn J-Y (2025) Efficacy and safety of clopidogrel versus aspirin monotherapy in patients at high risk of subsequent cardiovascular event after percutaneous coronary intervention (SMART-CHOICE 3): a randomised, open-label, multicentre trial. Lancet 405(10486):1252\u20131263.","journal-title":"Lancet"},{"issue":"2","key":"3998_CR102","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1161\/circulationaha.122.062770","volume":"147","author":"J Kang","year":"2023","unstructured":"Kang J, Park KW, Lee H, Hwang D, Yang H-M, Rha S-W, Bae J-W, Lee NH, Hur S-H, Han J-K, Shin E-S, Koo B-K, Kim H-S (2023) Aspirin Versus Clopidogrel for Long-Term Maintenance Monotherapy After Percutaneous Coronary Intervention: The HOST-EXAM Extended Study. Circulation 147(2):108\u2013117. https:\/\/doi.org\/10.1161\/circulationaha.122.062770","journal-title":"Circulation"},{"key":"3998_CR103","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/1607181","volume":"2019","author":"M del Paciaroni","year":"2019","unstructured":"Paciaroni M, Ince B, Hu B, Jeng J-S, Kutluk K, Liu L, Lou M, Parfenov V, Wong KSL, Zamani B, Paek D, Min Han J, del Aguila M, Girotra S (2019) Benefits and Risks of Clopidogrel vs. Aspirin Monotherapy after Recent Ischemic Stroke: A Systematic Review and Meta-Analysis. Cardiovasc Ther 2019:1\u201312. https:\/\/doi.org\/10.1155\/2019\/1607181","journal-title":"Cardiovasc Ther"},{"issue":"2","key":"3998_CR104","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jacc.2021.10.027","volume":"79","author":"JA Bittl","year":"2022","unstructured":"Bittl JA, Laine L (2022) Gastrointestinal Injury Caused by Aspirin or Clopidogrel Monotherapy Versus Dual Antiplatelet Therapy. J Am Coll Cardiol 79(2):129\u2013131. https:\/\/doi.org\/10.1016\/j.jacc.2021.10.027","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"3998_CR105","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD De Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann F-J, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM (2007) Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes. N Engl J Med 357(20):2001\u20132015. https:\/\/doi.org\/10.1056\/NEJMoa0706482","journal-title":"N Engl J Med"},{"issue":"1","key":"3998_CR106","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jjcc.2017.05.003","volume":"71","author":"K-H Park","year":"2018","unstructured":"Park K-H, Jeong MH, Kim HK, Ahn TH, Seung KB, Oh DJ, Choi D-J, Kim H-S, Gwon HC, Seong IW, Hwang KK, Chae SC, Kim K-B, Kim YJ, Cha KS, Oh SK, Chae JK (2018) Comparison of prasugrel versus clopidogrel in Korean patients with acute myocardial infarction undergoing successful revascularization. J Cardiol 71(1):36\u201343. https:\/\/doi.org\/10.1016\/j.jjcc.2017.05.003","journal-title":"J Cardiol"},{"issue":"4","key":"3998_CR107","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1136\/neurintsurg-2012-010334","volume":"5","author":"SH Akbari","year":"2013","unstructured":"Akbari SH, Reynolds MR, Kadkhodayan Y, Cross DT, Moran CJ (2013) Hemorrhagic complications after prasugrel (Effient) therapy for vascular neurointerventional procedures. J NeuroInterventional Surg 5(4):337\u2013343. https:\/\/doi.org\/10.1136\/neurintsurg-2012-010334","journal-title":"J NeuroInterventional Surg"},{"issue":"11","key":"3998_CR108","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA (2009) Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes. N Engl J Med 361(11):1045\u20131057. https:\/\/doi.org\/10.1056\/NEJMoa0904327","journal-title":"N Engl J Med"},{"issue":"27","key":"3998_CR109","doi-asserted-by":"publisher","first-page":"2520","DOI":"10.1056\/NEJMoa2111749","volume":"385","author":"Y Wang","year":"2021","unstructured":"Wang Y, Meng X, Wang A, Xie X, Pan Y, Johnston SC, Li H, Bath PM, Dong Q, Xu A, Jing J, Lin J, Niu S, Wang Y, Zhao X, Li Z, Jiang Y, Li W, Liu L, Xu J, Chang L, Wang L, Zhuang X, Zhao J, Feng Y, Man H, Li G, Wang B (2021) Ticagrelor versus Clopidogrel in CYP2C19 Loss-of-Function Carriers with Stroke or TIA. N Engl J Med 385(27):2520\u20132530. https:\/\/doi.org\/10.1056\/NEJMoa2111749","journal-title":"N Engl J Med"},{"issue":"4","key":"3998_CR110","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1161\/Circulationaha.109.921502","volume":"122","author":"SD Wiviott","year":"2010","unstructured":"Wiviott SD, Antman EM, Braunwald E (2010) Prasugrel Circulation 122(4):394\u2013403.","journal-title":"Prasugrel Circulation"},{"issue":"8","key":"3998_CR111","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1055\/s-0032-1328894","volume":"38","author":"S Jacob","year":"2012","unstructured":"Jacob S, Dunn BL, Qureshi ZP, Bandarenko N, Kwaan HC, Pandey DK, McKoy JM, Barnato SE, Winters JL, Cursio JF, Weiss I, Raife TJ, Carey PM, Sarode R, Kiss JE, Danielson C, Ortel TL, Clark WF, Rock G, Matsumoto M, Fujimura Y, Zheng XL, Chen H, Chen F, Armstrong JM, Raisch DW, Bennett CL (2012) Ticlopidine-, clopidogrel-, and prasugrel-associated thrombotic thrombocytopenic purpura: a 20-year review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost 38(8):845\u2013853. https:\/\/doi.org\/10.1055\/s-0032-1328894","journal-title":"Semin Thromb Hemost"},{"issue":"23","key":"3998_CR112","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/circulationaha.117.032180","volume":"137","author":"S Di Savonitto","year":"2018","unstructured":"Savonitto S, Ferri LA, Piatti L, Grosseto D, Piovaccari G, Morici N, Bossi I, Sganzerla P, Tortorella G, Cacucci M, Ferrario M, Murena E, Sibilio G, Tondi S, Toso A, Bongioanni S, Ravera A, Corrada E, Mariani M, Di Ascenzo L, Petronio AS, Cavallini C, Vitrella G, Rogacka R, Antonicelli R, Cesana BM, De Luca L, Ottani F, De Luca G, Piscione F, Moffa N, De Servi S, Bolognese L, Bovenzi F, Steffenino G, Santilli I, Bassanelli G, Sacco A, Canziani F, Ferri M, Lo Jacono E, Canosi U, Fornaro G, Leoncini M, Rosa Conte M, Farina R, Stefanin C, Di Pede F, Chella P, Chiara Nardoni M, Tamburrini P, Trimarco B, Galasso G, Elia R, Bolognese L, Grotti S, Bovenzi F, Borrelli L, Tamburino C, Capranzano P, Francaviglia B, Campana C, Bonatti R, Martinoni A, Abate F, Coscarelli S, Rubartelli P, Villani GQ, Rossini R (2018) Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization. Circulation 137(23):2435\u20132445. https:\/\/doi.org\/10.1161\/circulationaha.117.032180","journal-title":"Circulation"},{"key":"3998_CR113","doi-asserted-by":"publisher","unstructured":"Nazir A, Vijay SK, Singh AK, Tiwari BC, Afroz E, Jamwal N, Jha A, Singh R, Thandi P, Qutubuddin Q (2024) Clinical and peri procedural outcomes using reduced dose prasugrel vs standard dose ticagrelor in elderly patients of acute coronary syndrome undergoing PCI. European Heart Journal 45 (Supplement_1) https:\/\/doi.org\/10.1093\/eurheartj\/ehae666.1628","DOI":"10.1093\/eurheartj\/ehae666.1628"},{"issue":"4","key":"3998_CR114","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1007\/s12928-025-01129-2","volume":"40","author":"T Fujii","year":"2025","unstructured":"Fujii T, Amano K, Kasai S, Kawamura Y, Yoshimachi F, Ikari Y (2025) Efficacy and safety of low-dose prasugrel as dual antiplatelet therapy in patients with ischemic heart disease: a systematic review and network meta-analysis of randomized controlled trials. Cardiovasc Intervention Ther 40(4):767\u2013777. https:\/\/doi.org\/10.1007\/s12928-025-01129-2","journal-title":"Cardiovasc Intervention Ther"},{"issue":"4","key":"3998_CR115","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1093\/ehjcvp\/pvz056","volume":"6","author":"Y Maekawa","year":"2020","unstructured":"Maekawa Y, Nakamura M, Kadota K, Amano T, Ishii H, Numasawa Y, Kohsaka S, Yamaji K, Inohara T, Akita K (2020) Impact of reduced-dose prasugrel vs. standard-dose clopidogrel on in-hospital outcomes of percutaneous coronary intervention in 62 737 patients with acute coronary syndromes: a nationwide registry study in Japan. Eur Heart J - Cardiovasc Pharmacotherapy 6(4):231\u2013238. https:\/\/doi.org\/10.1093\/ehjcvp\/pvz056","journal-title":"Eur Heart J - Cardiovasc Pharmacotherapy"},{"key":"3998_CR116","doi-asserted-by":"publisher","unstructured":"Honda S, Lee S, Cho KH, Takegami M, Nishihira K, Kojima S, Asaumi Y, Saji M, Yamashita J, Hibi K, Takahashi J, Sakata Y, Takayama M, Sumiyoshi T, Ogawa H, Kimura K, Sim DS, Kim HK, Kim W, Ahn Y, Jeong MH, Yasuda S (2024) Clinical outcomes of adjusted-dose versus standard-dose prasugrel in East Asian patients with acute myocardial infarction. Int J Cardiol 410. https:\/\/doi.org\/10.1016\/j.ijcard.2024.132197","DOI":"10.1016\/j.ijcard.2024.132197"},{"issue":"3","key":"3998_CR117","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1002\/cpt.3209","volume":"116","author":"ML Tsai","year":"2024","unstructured":"Tsai ML, Lin Y, Chen DY, Lin MS, Wang CY, Hsieh IC, Yang NI, Hung MJ, Chen TH (2024) Ticagrelor versus Adjusted-Dose Prasugrel in Acute Coronary Syndrome with Percutaneous Coronary Intervention. Clin Pharmacol Ther 116(3):747\u2013756.","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"3998_CR118","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s11239-024-02965-4","volume":"57","author":"Y-J Wu","year":"2024","unstructured":"Wu Y-J, Wu C-C, Huang H-Y, Wu C-Y, Huang C-C, Wang C-C (2024) Low-dose prasugrel versus standard-dose ticagrelor in east Asian patients with acute coronary syndrome. J Thromb Thrombolysis 57(4):537\u2013546. https:\/\/doi.org\/10.1007\/s11239-024-02965-4","journal-title":"J Thromb Thrombolysis"},{"issue":"23","key":"3998_CR119","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.1182\/blood-2016-10-743930","volume":"128","author":"WA Parker","year":"2016","unstructured":"Parker WA, Storey RF (2016) Ticagrelor: agonising over its mechanisms of action. Blood 128(23):2595\u20132597. https:\/\/doi.org\/10.1182\/blood-2016-10-743930","journal-title":"Blood"},{"key":"3998_CR120","doi-asserted-by":"crossref","unstructured":"Li X, Wang Q, Xue Y, Chen J, Lv Q (2017) Ticagrelor Compared with Clopidogrel Increased Adenosine and Cyclic Adenosine Monophosphate Plasma Concentration in Acute Coronary Syndrome Patients. Basic & clinical pharmacology & toxicology 120 (6): 610-614 DOI 10.1111\/bcpt.12752","DOI":"10.1111\/bcpt.12752"},{"issue":"7","key":"3998_CR121","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jacc.2012.11.032","volume":"61","author":"A van Wittfeldt","year":"2013","unstructured":"Wittfeldt A, Emanuelsson H, Brandrup-Wognsen G, van Giezen JJ, Jonasson J, Nylander S, Gan LM (2013) Ticagrelor enhances adenosine-induced coronary vasodilatory responses in humans. J Am Coll Cardiol 61(7):723\u2013727. https:\/\/doi.org\/10.1016\/j.jacc.2012.11.032","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"3998_CR122","doi-asserted-by":"publisher","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","volume":"120","author":"PA Gurbel","year":"2009","unstructured":"111.Gurbel PA, Bliden KP, Butler K, Tantry US, Gesheff T, Wei C, Teng R, Antonino MJ, Patil SB, Karunakaran A, Kereiakes DJ, Parris C, Purdy D, Wilson V, Ledley GS, Storey RF (2009) Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study. Circulation 120(25):2577\u20132585.","journal-title":"Circulation"},{"issue":"16","key":"3998_CR123","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1056\/NEJMoa1908973","volume":"381","author":"S Sch\u00fcpke","year":"2019","unstructured":"Sch\u00fcpke S, Neumann F-J, Menichelli M, Mayer K, Bernlochner I, W\u00f6hrle J, Richardt G, Liebetrau C, Witzenbichler B, Antoniucci D, Akin I, Bott-Fl\u00fcgel L, Fischer M, Landmesser U, Katus HA, Sibbing D, Seyfarth M, Janisch M, Boncompagni D, Hilz R, Rottbauer W, Okrojek R, M\u00f6llmann H, Hochholzer W, Migliorini A, Cassese S, Mollo P, Xhepa E, Kufner S, Strehle A, Leggewie S, Allali A, Ndrepepa G, Sch\u00fchlen H, Angiolillo DJ, Hamm CW, Hapfelmeier A, T\u00f6lg R, Trenk D, Schunkert H, Laugwitz K-L, Kastrati A (2019) Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes. N Engl J Med 381(16):1524\u20131534. https:\/\/doi.org\/10.1056\/NEJMoa1908973","journal-title":"N Engl J Med"},{"issue":"24","key":"3998_CR124","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1161\/circulationaha.120.050244","volume":"142","author":"A Aytekin","year":"2020","unstructured":"Aytekin A, Ndrepepa G, Neumann F-J, Menichelli M, Mayer K, W\u00f6hrle J, Bernlochner I, Lahu S, Richardt G, Witzenbichler B, Sibbing D, Cassese S, Angiolillo DJ, Valina C, Kufner S, Liebetrau C, Hamm CW, Xhepa E, Hapfelmeier A, Sager HB, Wustrow I, Joner M, Trenk D, Fusaro M, Laugwitz K-L, Schunkert H, Sch\u00fcpke S, Kastrati A (2020) Ticagrelor or Prasugrel in Patients With ST-Segment\u2013Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Circulation 142(24):2329\u20132337. https:\/\/doi.org\/10.1161\/circulationaha.120.050244","journal-title":"Circulation"},{"key":"3998_CR125","doi-asserted-by":"publisher","unstructured":"Kr\u00fcger N, Krefting J, Kessler T, Schmieder R, Starnecker F, Dutsch A, Graesser C, Meyer-Lindemann U, Storz T, Pugach I, Frie\u00df C, Chen Z, Bongiovanni D, Manea I, Dreischulte T, Offenborn F, Krase P, Sager HB, Wiebe J, Kufner S, Xhepa E, Joner M, Trenkwalder T, Gueldener U, Kastrati A, Cassese S, Schunkert H, von Scheidt M, Adam J, Anselm R, Ates S, Bauer S, Beck N, Beckmann J, Berutti R, Brandmaier S, Bruun T, Cassese S, Decker M, Dichgans M, Diesselhorst P, Domdey H, Doppler S, Dre\u00dfen M, Dressler A, Dufour F, Duscha S, Eckstein HH, Farzeen A, Feiler T, Friess C, Gall I, Gassner UM, Gieger C, Gotor-Blazquez M, Gueldener U, Hammer N, Hawe J, Heidel V, Hendel T, Holdenrieder S, Jonas S, Kameric M, Kastrati A, Kessler T, Knoedlseder K, Koenig W, Kohlmayer F, Krane M, Kranzelmueller D, Krefting J, Kr\u00fcger N, Kroke A, Lahm H, Lange R, Lehmann A, Li L, Linkohr B, Maegdefessel L, Mann M, Malik R, Meitinger T, Neb I, O\u2019Hehir T, Pang S, Perl B, Peters A, Peymani F, Pichler R, Pfister H, Pisano P, Prokisch H, Pugach I, Reimer LM, Sander M, Sanin V, Schlieben LD, Schlote Y, Schmid S, Schmieder RS, Schunkert H, Schwab M, Sharikadze M, Sinha A, Starnecker F, Steger M, Steigerwald S, Sun R, von Scheidt M, Wagner M, Westerlund A, Wiehler J, Wierer M, Zinterhof P (2024) Ticagrelor vs Prasugrel for Acute Coronary Syndrome in Routine Care. JAMA Network Open 7 (12) https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.48389","DOI":"10.1001\/jamanetworkopen.2024.48389"},{"issue":"3","key":"3998_CR126","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1056\/NEJMoa1916870","volume":"383","author":"SC Johnston","year":"2020","unstructured":"Johnston SC, Amarenco P, Denison H, Evans SR, Himmelmann A, James S, Knutsson M, Ladenvall P, Molina CA, Wang Y (2020) Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA. N Engl J Med 383(3):207\u2013217. https:\/\/doi.org\/10.1056\/NEJMoa1916870","journal-title":"N Engl J Med"},{"issue":"5","key":"3998_CR127","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s40263-024-01080-5","volume":"38","author":"MG Zeinhom","year":"2024","unstructured":"Zeinhom MG, Elbassiouny A, Mohamed AM, Ahmed SR (2024) Ticagrelor Versus Clopidogrel in Acute Large-Vessel Ischemic Stroke: A Randomized Controlled Single-Blinded Trial. CNS Drugs 38(5):387\u2013398. https:\/\/doi.org\/10.1007\/s40263-024-01080-5","journal-title":"CNS Drugs"},{"issue":"1","key":"3998_CR128","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40263-024-01127-7","volume":"39","author":"SR Ahmed","year":"2024","unstructured":"Ahmed SR, Nahas NE, Khalil MFE, Elbassiouny A, Almoataz MA, Omar TY, Daabis AMA, Refat HM, Ebied AAMK, Hassan AM, Mohamed DMA, Ismaiel M, Zeinhom MG (2024) TICA-CLOP STUDY: Ticagrelor Versus Clopidogrel in Acute Moderate and Moderate-to-Severe Ischemic Stroke, a Randomized Controlled Multi-Center Trial. CNS Drugs 39(1):81\u201393. https:\/\/doi.org\/10.1007\/s40263-024-01127-7","journal-title":"CNS Drugs"},{"key":"3998_CR129","doi-asserted-by":"crossref","unstructured":"Lee Y, Shin J-H, Seo SM, Choi IJ, Lee J-Y, Lee J-W, Park M-W, Kang TS, Choi WG, Jeon K-H, Lim H-S, Joo HJ, Rhee SJ, Seo J-B, Park MS, Park S-H, Lim Y-H (2023) Influence of early dose reduction of ticagrelor on clinical outcomes following percutaneous coronary intervention for complex lesions. Sci Rep 13(1).","DOI":"10.1038\/s41598-023-42655-4"},{"key":"3998_CR130","doi-asserted-by":"crossref","unstructured":"Granger CB, Berger PB (2016) Understanding the Adverse Effects of Ticagrelor in Practice. JAMA Cardiol 1(4).","DOI":"10.1001\/jamacardio.2016.1018"},{"key":"3998_CR131","doi-asserted-by":"crossref","unstructured":"Wei P, Wang X, Fu Q, Cao B (2024) Progress in the clinical effects and adverse reactions of ticagrelor. Thromb J 22(1).","DOI":"10.1186\/s12959-023-00559-3"},{"issue":"13","key":"3998_CR132","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1161\/circulationaha.118.034790","volume":"138","author":"RC Orme","year":"2018","unstructured":"Orme RC, Parker WAE, Thomas MR, Judge HM, Baster K, Sumaya W, Morgan KP, McMellon HC, Richardson JD, Grech ED, Wheeldon NM, Hall IR, Iqbal J, Barmby D, Gunn JP, Storey RF, Wilcox RG, Walsh JT, Smith W, Skene A (2018) Study of Two Dose Regimens of Ticagrelor Compared With Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention for Stable Coronary Artery Disease. Circulation 138(13):1290\u20131300.","journal-title":"Circulation"},{"issue":"14","key":"3998_CR133","doi-asserted-by":"publisher","first-page":"1594","DOI":"10.1016\/j.jacc.2018.02.010","volume":"71","author":"D-W Park","year":"2018","unstructured":"Park D-W, Lee PH, Jang S, Lim H-S, Kang D-Y, Lee CH, Ahn J-M, Yun S-C, Park S-W, Park S-J (2018) Effect of Low-Dose Versus Standard-Dose Ticagrelor and Clopidogrel on Platelet Inhibition in Acute Coronary Syndromes. J Am Coll Cardiol 71(14):1594\u20131595. https:\/\/doi.org\/10.1016\/j.jacc.2018.02.010","journal-title":"J Am Coll Cardiol"},{"issue":"1141","key":"3998_CR134","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1136\/postgradmedj-2019-137180","volume":"96","author":"Q Chen","year":"2020","unstructured":"Chen Q, Zhang Y, Wang Z, Wang S, Zhang H, Wang Y, Lu C, Xuan H, Wang C, Li D, Xu T (2020) Efficacy and safety of low dose ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis. Postgrad Med J 96(1141):693\u2013702.","journal-title":"Postgrad Med J"},{"issue":"5","key":"3998_CR135","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s40262-023-01245-3","volume":"62","author":"L Ortega-Paz","year":"2023","unstructured":"Ortega-Paz L, Giordano S, Franchi F, Rollini F, Pollack CV, Bhatt DL, Angiolillo DJ (2023) Clinical and Pre-Clinical Pharmacokinetics and Pharmacodynamics of Bentracimab. Clin Pharmacokinet 62(5):673\u2013692.","journal-title":"Clin Pharmacokinet"},{"key":"3998_CR136","doi-asserted-by":"publisher","unstructured":"Bhatt DL, Pollack CV, Mazer CD, Angiolillo DJ, Steg PG, James SK, Weitz JI, Ramnath R, Arnold SE, Mays MC, Umstead BR, White B, Hickey LL, Jennings LK, Curry BJ, Lee JS, Verma S (2022) Bentracimab for Ticagrelor Reversal in Patients Undergoing Urgent Surgery. NEJM Evidence 1(3). https:\/\/doi.org\/10.1056\/EVIDoa2100047","DOI":"10.1056\/EVIDoa2100047"},{"key":"3998_CR137","doi-asserted-by":"crossref","unstructured":"Cattaneo M (2010) New P2Y(12) inhibitors. Circulation 121(1):171\u2013179.","DOI":"10.1161\/CIRCULATIONAHA.109.853069"},{"key":"3998_CR138","doi-asserted-by":"publisher","unstructured":"De Luca L, Steg PG, Bhatt DL, Capodanno D, Angiolillo DJ (2021) Cangrelor: Clinical Data, Contemporary Use, and Future Perspectives. J Am Heart Association 10(13). https:\/\/doi.org\/10.1161\/jaha.121.022125","DOI":"10.1161\/jaha.121.022125"},{"issue":"18","key":"3998_CR139","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/j.jcin.2016.06.046","volume":"9","author":"J Abtan","year":"2016","unstructured":"Abtan J, Steg PG, Stone GW, Mahaffey KW, Gibson CM, Hamm CW, Price MJ, Abnousi F, Prats J, Deliargyris EN, White HD, Harrington RA, Bhatt DL (2016) Efficacy and Safety of Cangrelor in Preventing Periprocedural Complications in Patients With Stable Angina and Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention. JACC: Cardiovasc Interventions 9(18):1905\u20131913. https:\/\/doi.org\/10.1016\/j.jcin.2016.06.046","journal-title":"JACC: Cardiovasc Interventions"},{"key":"3998_CR140","doi-asserted-by":"publisher","unstructured":"Douketis JD, Hardin CC, Spyropoulos AC (2023) Perioperative Management of Anticoagulant and Antiplatelet Therapy. NEJM Evid 2(6). https:\/\/doi.org\/10.1056\/EVIDra2200322","DOI":"10.1056\/EVIDra2200322"},{"issue":"5","key":"3998_CR141","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.jcin.2017.10.051","volume":"11","author":"R Rossini","year":"2018","unstructured":"Rossini R, Tarantini G, Musumeci G, Masiero G, Barbato E, Calabr\u00f2 P, Capodanno D, Leonardi S, Lettino M, Limbruno U, Menozzi A, Marchese UOA, Saia F, Valgimigli M, Ageno W, Falanga A, Corcione A, Locatelli A, Montorsi M, Piazza D, Stella A, Bozzani A, Parolari A, Carone R, Angiolillo DJ (2018) A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery. JACC: Cardiovasc Interventions 11(5):417\u2013434. https:\/\/doi.org\/10.1016\/j.jcin.2017.10.051","journal-title":"JACC: Cardiovasc Interventions"},{"issue":"12","key":"3998_CR142","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1038\/s41569-023-00901-2","volume":"20","author":"DA ten Gorog","year":"2023","unstructured":"Gorog DA, Ferreiro JL, Ahrens I, Ako J, Geisler T, Halvorsen S, Huber K, Jeong Y-H, Navarese EP, Rubboli A, Sibbing D, Siller-Matula JM, Storey RF, Tan JWC, ten Berg JM, Valgimigli M, Vandenbriele C, Lip GYH (2023) De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis. Nat Reviews Cardiol 20(12):830\u2013844. https:\/\/doi.org\/10.1038\/s41569-023-00901-2","journal-title":"Nat Reviews Cardiol"},{"key":"3998_CR143","doi-asserted-by":"crossref","unstructured":"Spirito A, Krishnan SL, Capodanno D, Angiolillo DJ, Mehran R (2024) Antiplatelet De-Escalation Strategies in Patients Undergoing Percutaneous Coronary Intervention. Circulation: Cardiovasc Interventions 17(4).","DOI":"10.1161\/CIRCINTERVENTIONS.123.013263"},{"key":"3998_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2025.08.040","author":"R De Piccolo","year":"2025","unstructured":"Piccolo R, Calabr\u00f2 P, Carrara G, Simonetti F, Varricchio A, Attisano T, Napolitano G, De Simone C, Carpinella G, Stabile E, Cirillo P, Di Serafino L, Caiazzo G, Tesorio T, Boccalatte M, Tuccillo B, Avvedimento M, Leone A, Galasso G, Cesaro A, Perrotta R, Niglio T, Castiello DS, Molaro MI, Bardi L, Spinelli A, Cristiano S, Bellino M, Leonardi S, Biscaglia S, Costa F, Cassese S, McFadden E, Heg D, Stefanini GG, Franzone A, Capodanno D, Esposito G (2025) Personalized or Standard Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention: PARTHENOPE Randomized Trial. Jacc DOI https:\/\/doi.org\/10.1016\/j.jacc.2025.08.040","journal-title":"Jacc DOI"},{"issue":"7","key":"3998_CR145","doi-asserted-by":"publisher","first-page":"339","DOI":"10.2459\/jcm.0000000000001737","volume":"26","author":"M Di Spagnolo","year":"2025","unstructured":"Spagnolo M, Laudani C, Imbesi A, Di Leo G, Ammirabile N, Finocchiaro S, Mauro MS, Mazzone PM, Greco A, Giacoppo D, Capodanno D (2025) Dual antiplatelet therapy de-escalation by discontinuation in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis. J Cardiovasc Med 26(7):339\u2013348. https:\/\/doi.org\/10.2459\/jcm.0000000000001737","journal-title":"J Cardiovasc Med"},{"issue":"31","key":"3998_CR146","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","volume":"40","author":"P Urban","year":"2019","unstructured":"Urban P, Mehran R, Colleran R, Angiolillo DJ, Byrne RA, Capodanno D, Cuisset T, Cutlip D, Eerdmans P, Eikelboom J, Farb A, Gibson CM, Gregson J, Haude M, James SK, Kim H-S, Kimura T, Konishi A, Laschinger J, Leon MB, Magee PFA, Mitsutake Y, Mylotte D, Pocock S, Price MJ, Rao SV, Spitzer E, Stockbridge N, Valgimigli M, Varenne O, Windhoevel U, Yeh RW, Krucoff MW, Morice M-C (2019) Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High Bleeding Risk. Eur Heart J 40(31):2632\u20132653. https:\/\/doi.org\/10.1093\/eurheartj\/ehz372","journal-title":"Eur Heart J"},{"issue":"19","key":"3998_CR147","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1016\/j.jacc.2016.02.064","volume":"67","author":"U Baber","year":"2016","unstructured":"Baber U, Mehran R, Giustino G, Cohen DJ, Henry TD, Sartori S, Ariti C, Litherland C, Dangas G, Gibson CM, Krucoff MW, Moliterno DJ, Kirtane AJ, Stone GW, Colombo A, Chieffo A, Kini AS, Witzenbichler B, Weisz G, Steg PG, Pocock S (2016) Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents. J Am Coll Cardiol 67(19):2224\u20132234. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.064","journal-title":"J Am Coll Cardiol"},{"key":"3998_CR148","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijcard.2017.10.103","volume":"254","author":"S Raposeiras-Roub\u00edn","year":"2018","unstructured":"Raposeiras-Roub\u00edn S, Fax\u00e9n J, \u00cd\u00f1iguez-Romo A, Henriques JPS, D\u2019Ascenzo F, Saucedo J, Szummer K, Jernberg T, James SK, Juanatey JRG, Wilton SB, Kikkert WJ, Nu\u00f1ez-Gil I, Ariza-Sole A, Song X, Alexopoulos D, Liebetrau C, Kawaji T, Moretti C, Huczek Z, Nie S-P, Fujii T, Correia L, Kawashiri M-a, Caneiro-Queija B, Cobas-Paz R, Acu\u00f1a JMG, Southern D, Alfonso E, Terol B, Garay A, Zhang D, Chen Y, Xanthopoulou I, Osman N, M\u00f6llmann H, Shiomi H, Giordana F, Gaita F, Kowara M, Filipiak K, Wang X, Yan Y, Fan J-Y, Ikari Y, Nakahayshi T, Sakata K, Yamagishi M, Kalpak O, Kedev S, Rivera-Asenjo D, Abu-Assi E (2018) Development and external validation of a post-discharge bleeding risk score in patients with acute coronary syndrome: The BleeMACS score. Int J Cardiol 254:10\u201315. https:\/\/doi.org\/10.1016\/j.ijcard.2017.10.103","journal-title":"Int J Cardiol"},{"issue":"18","key":"3998_CR149","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","volume":"385","author":"M Valgimigli","year":"2021","unstructured":"Valgimigli M, Frigoli E, Heg D, Tijssen J, J\u00fcni P, Vranckx P, Ozaki Y, Morice M-C, Chevalier B, Onuma Y, Windecker S, Tonino PAL, Roffi M, Lesiak M, Mahfoud F, Bartunek J, Hildick-Smith D, Colombo A, Stankovi\u0107 G, I\u00f1iguez A, Schultz C, Kornowski R, Ong PJL, Alasnag M, Rodriguez AE, Moschovitis A, Laanmets P, Donahue M, Leonardi S, Smits PC (2021) Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk. N Engl J Med 385(18):1643\u20131655. https:\/\/doi.org\/10.1056\/NEJMoa2108749","journal-title":"N Engl J Med"},{"issue":"16","key":"3998_CR150","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/j.jcin.2021.06.003","volume":"14","author":"S-J Hong","year":"2021","unstructured":"Hong S-J, Kim J-S, Hong SJ, Lim D-S, Lee S-Y, Yun KH, Park J-K, Kang WC, Kim YH, Yoon H-J, Won H, Nam C-M, Ahn C-M, Kim B-K, Ko Y-G, Choi D, Jang Y, Hong M-K (2021) 1-Month Dual-Antiplatelet Therapy Followed by Aspirin Monotherapy After Polymer-Free Drug-Coated Stent Implantation. JACC: Cardiovasc Interventions 14(16):1801\u20131811. https:\/\/doi.org\/10.1016\/j.jcin.2021.06.003","journal-title":"JACC: Cardiovasc Interventions"},{"key":"3998_CR151","doi-asserted-by":"publisher","unstructured":"Feres F, Jama (2013) https:\/\/doi.org\/10.1001\/jama.2013.282183","DOI":"10.1001\/jama.2013.282183"},{"issue":"15","key":"3998_CR152","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.jacc.2012.06.043","volume":"60","author":"B-K Kim","year":"2012","unstructured":"Kim B-K, Hong M-K, Shin D-H, Nam C-M, Kim J-S, Ko Y-G, Choi D, Kang T-S, Park B-E, Kang W-C, Lee S-H, Yoon J-H, Hong B-K, Kwon H-M, Jang Y (2012) A New Strategy for Discontinuation of Dual Antiplatelet Therapy. J Am Coll Cardiol 60(15):1340\u20131348. https:\/\/doi.org\/10.1016\/j.jacc.2012.06.043","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"3998_CR153","doi-asserted-by":"publisher","first-page":"e990","DOI":"10.4244\/eij-d-19-00539","volume":"15","author":"G De Luca","year":"2019","unstructured":"De Luca G, Damen SA, Camaro C, Benit E, Verdoia M, Rasoul S, Liew HB, Polad J, Ahmad WA, Zambahari R, Postma S, Kedhi E, Suryapranata H (2019) Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial). EuroIntervention 15(11):e990\u2013e998. https:\/\/doi.org\/10.4244\/eij-d-19-00539","journal-title":"EuroIntervention"},{"key":"3998_CR154","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k3793","author":"E van der Kedhi","year":"2018","unstructured":"Kedhi E, Fabris E, van der Ent M, Buszman P, von Birgelen C, Roolvink V, Zurakowski A, Schotborgh CE, Hoorntje JCA, Eek CH, Cook S, Togni M, Meuwissen M, van Royen N, van Vliet R, Wedel H, Delewi R, Zijlstra F (2018) Six months versus 12 months dual antiplatelet therapy after drug-eluting stent implantation in ST-elevation myocardial infarction (DAPT-STEMI): randomised, multicentre, non-inferiority trial. BMJ.","journal-title":"BMJ"},{"issue":"10127","key":"3998_CR155","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1016\/s0140-6736(18)30493-8","volume":"391","author":"J-Y Hahn","year":"2018","unstructured":"Hahn J-Y, Song YB, Oh J-H, Cho D-K, Lee JB, Doh J-H, Kim S-H, Jeong J-O, Bae J-H, Kim B-O, Cho JH, Suh I-W, Kim D-i, Park H-K, Park J-S, Choi WG, Lee WS, Kim J, Choi KH, Park TK, Lee JM, Yang JH, Choi J-H, Choi S-H, Gwon H-C, Gwon H-C, Hahn J-Y, Song YB, Park TK, Lee JM, Yang JH, Choi J-H, Choi S-H, Lee J-Y, Choi WG, Bae J-H, Park HS, Hwang J-Y, Hur S-H, Rha S-W, Cho D-K, Cho SC, Kang WY, Lim S-H, Lee JB, Kim MH, Cha KS, Choi RK, Chae I-H, Oh J-H, Jang WJ, Park YH, Chun WJ, Kim S-H, Cho JH, Suh I-W, Park J-S, Choi JW, Kim B-O, Doh J-H, Kim D-i, Jeong MH, Kang SH, Lee WS, Park H-K, Jeong J-O, Ahn K-J (2018) 6-month versus 12-month or longer dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (SMART-DATE): a randomised, open-label, non-inferiority trial. Lancet 391(10127):1274\u20131284.","journal-title":"Lancet"},{"issue":"2","key":"3998_CR156","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jcin.2012.09.012","volume":"6","author":"M Kerneis","year":"2013","unstructured":"Kerneis M, Silvain J, Abtan J, Cayla G, O\u2019Connor SA, Barth\u00e9l\u00e9my O, Vignalou J-B, Beygui F, Brugier D, Martin R, Collet J-P, Montalescot G (2013) Switching Acute Coronary Syndrome Patients From Prasugrel to Clopidogrel. JACC: Cardiovasc Interventions 6(2):158\u2013165. https:\/\/doi.org\/10.1016\/j.jcin.2012.09.012","journal-title":"JACC: Cardiovasc Interventions"},{"issue":"10308","key":"3998_CR157","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/s0140-6736(21)01445-8","volume":"398","author":"CJ Kim","year":"2021","unstructured":"Kim CJ, Park M-W, Kim MC, Choo E-H, Hwang B-H, Lee KY, Choi YS, Kim H-Y, Yoo K-D, Jeon D-S, Shin E-S, Jeong Y-H, Seung K-B, Jeong MH, Yim HW, Ahn Y, Chang K, Kim CJ, Park M-W, Kim MC, Choo E-H, Hwang B-H, Lee KY, Choi YS, Kim H-Y, Yoo K-D, Jeon D-S, Shin E-S, Jeong Y-H, Seung K-B, Jeon MH, Ahn Y, Chang K, Oh J-H, Ha SJ, Baek JY, Jung KT, Doh J-H, Kim W, Kim D-B, Cha KS, Yoon M-H, Hur S-H, Lee S-H, Cho B-R, Park J-S, Koh JS, Kim S-H, Cho JH, Shim BJ, Kim SW, Jang J-S, Kim K-S, Shin W-Y, Sung K-C (2021) Unguided de-escalation from ticagrelor to clopidogrel in stabilised patients with acute myocardial infarction undergoing percutaneous coronary intervention (TALOS-AMI): an investigator-initiated, open-label, multicentre, non-inferiority, randomised trial. Lancet 398(10308):1305\u20131316.","journal-title":"Lancet"},{"key":"3998_CR158","doi-asserted-by":"publisher","unstructured":"Wang X, Xi S, Liu J, Qin L, Jing J, Yin T, Chen Y (2016) Switching between ticagrelor and clopidogrel in patients who underwent percutaneous coronary intervention: insight into contemporary practice in Chinese patients. European Heart Journal Supplements 18 (suppl F): F19-F26 https:\/\/doi.org\/10.1093\/eurheartj\/suw034","DOI":"10.1093\/eurheartj\/suw034"},{"key":"3998_CR159","doi-asserted-by":"publisher","unstructured":"Hwang D, Lim Y-H, Park KW, Chun KJ, Han J-K, Yang H-M, Kang H-J, Koo B-K, Kang J, Cho Y-K, Hong SJ, Kim S, Jo S-H, Kim YH, Kim W, Lee SY, Kim YD, Oh SK, Lee J-H, Kim H-S, Rhew JY, Bong JM, Bae J-W, Lee BK, Kim S-Y, Park K-H, Rha S-W, Shin W-Y, Lim H-S, Park K, Kim D-B, Chae I-H, Moon K-W, Park HW, Won K-B, Jeon DW, Han G-R, Choi SW, Ryu JK, Jeong MH, Cha KS, Lee N, Kang D-Y, Song YB (2022) Prasugrel Dose De-escalation Therapy After Complex Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome. JAMA Cardiol 7(4). https:\/\/doi.org\/10.1001\/jamacardio.2022.0052","DOI":"10.1001\/jamacardio.2022.0052"},{"issue":"10257","key":"3998_CR160","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/s0140-6736(20)31791-8","volume":"396","author":"H-S Kim","year":"2020","unstructured":"Kim H-S, Kang J, Hwang D, Han J-K, Yang H-M, Kang H-J, Koo B-K, Rhew JY, Chun K-J, Lim Y-H, Bong JM, Bae J-W, Lee BK, Park KW (2020) Prasugrel-based de-escalation of dual antiplatelet therapy after percutaneous coronary intervention in patients with acute coronary syndrome (HOST-REDUCE-POLYTECH-ACS): an open-label, multicentre, non-inferiority randomised trial. Lancet 396(10257):1079\u20131089.","journal-title":"Lancet"},{"issue":"23","key":"3998_CR161","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1056\/NEJMoa1409312","volume":"371","author":"L Mauri","year":"2014","unstructured":"Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand S-LT, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM (2014) Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents. N Engl J Med 371(23):2155\u20132166. https:\/\/doi.org\/10.1056\/NEJMoa1409312","journal-title":"N Engl J Med"},{"issue":"19","key":"3998_CR162","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1056\/NEJMoa1500857","volume":"372","author":"MP Bonaca","year":"2015","unstructured":"Bonaca MP, Bhatt DL, Cohen M, Steg PG, Storey RF, Jensen EC, Magnani G, Bansilal S, Fish MP, Im K, Bengtsson O, Ophuis TO, Budaj A, Theroux P, Ruda M, Hamm C, Goto S, Spinar J, Nicolau JC, Kiss RG, Murphy SA, Wiviott SD, Held P, Braunwald E, Sabatine MS (2015) Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction. N Engl J Med 372(19):1791\u20131800. https:\/\/doi.org\/10.1056\/NEJMoa1500857","journal-title":"N Engl J Med"},{"issue":"14","key":"3998_CR163","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1056\/NEJMoa1908077","volume":"381","author":"PG Steg","year":"2019","unstructured":"Steg PG, Bhatt DL, Simon T, Fox K, Mehta SR, Harrington RA, Held C, Andersson M, Himmelmann A, Ridderstr\u00e5le W, Leonsson-Zachrisson M, Liu Y, Opolski G, Zateyshchikov D, Ge J, Nicolau JC, Corbal\u00e1n R, Cornel JH, Widimsk\u00fd P, Leiter LA (2019) Ticagrelor in Patients with Stable Coronary Disease and Diabetes. N Engl J Med 381(14):1309\u20131320. https:\/\/doi.org\/10.1056\/NEJMoa1908077","journal-title":"N Engl J Med"},{"issue":"10","key":"3998_CR164","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1080\/14779072.2022.2137492","volume":"20","author":"PM Mazzone","year":"2022","unstructured":"Mazzone PM, Angiolillo DJ, Capodanno D (2022) Approaches to de-escalation of antiplatelet treatment in stabilized post-myocardial infarction patients with high ischemic risk. Expert Rev Cardiovasc Ther 20(10):839\u2013849.","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"12","key":"3998_CR165","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jacc.2024.06.038","volume":"84","author":"WWA van den Broek","year":"2024","unstructured":"van den Broek WWA, Ingraham BS, Pereira NL, Lee CR, Cavallari LH, Swen JJ, Angiolillo DJ, ten Berg JM (2024) Genotype-Guided Antiplatelet Therapy. J Am Coll Cardiol 84(12):1107\u20131118. https:\/\/doi.org\/10.1016\/j.jacc.2024.06.038","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"3998_CR166","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jcin.2010.12.011","volume":"4","author":"D Alexopoulos","year":"2011","unstructured":"Alexopoulos D, Dimitropoulos G, Davlouros P, Xanthopoulou I, Kassimis G, Stavrou EF, Hahalis G, Athanassiadou A (2011) JACC: Cardiovasc Interventions 4(4):403\u2013410. . Prasugrel Overcomes High On-Clopidogrel Platelet Reactivity Post-Stenting More Effectively Than High-Dose (150-mg) Clopidogrel https:\/\/doi.org\/10.1016\/j.jcin.2010.12.011","journal-title":"JACC: Cardiovasc Interventions"},{"issue":"6","key":"3998_CR167","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/jth.12907","volume":"13","author":"G Lemesle","year":"2015","unstructured":"Lemesle G, Schurtz G, Bauters C, Hamon M (2015) High on-treatment platelet reactivity with ticagrelor versus prasugrel: a systematic review and meta-analysis. J Thromb Haemost 13(6):931\u2013942. https:\/\/doi.org\/10.1111\/jth.12907","journal-title":"J Thromb Haemost"},{"issue":"7","key":"3998_CR168","doi-asserted-by":"publisher","first-page":"506","DOI":"10.3109\/09537104.2013.845874","volume":"25","author":"NP Dridi","year":"2013","unstructured":"Dridi NP, Johansson PI, Clemmensen P, Stissing T, Radu MD, Qayyum A, Pedersen F, Helqvist S, Saunam\u00e4ki K, Kelb\u00e6k H, J\u00f8rgensen E, Engstr\u00f8m T, Holmvang L (2013) Prasugrel or double-dose clopidogrel to overcome clopidogrel low-response \u2013 The TAILOR (Thrombocytes And IndividuaLization of ORal antiplatelet therapy in percutaneous coronary intervention) randomized trial. Platelets 25(7):506\u2013512. https:\/\/doi.org\/10.3109\/09537104.2013.845874","journal-title":"Platelets"},{"key":"3998_CR169","doi-asserted-by":"publisher","unstructured":"Pereira NL, Cresci S, Angiolillo DJ, Batchelor W, Capers Q, Cavallari LH, Leifer D, Luzum JA, Roden DM, Stellos K, Turrise SL, Tuteja S (2024) CYP2C19 Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association. Circulation 150(6). https:\/\/doi.org\/10.1161\/cir.0000000000001257","DOI":"10.1161\/cir.0000000000001257"},{"issue":"5","key":"3998_CR170","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/09537104.2020.1792871","volume":"32","author":"M Biswas","year":"2020","unstructured":"Biswas M, Kali MSK, Biswas TK, Ibrahim B (2020) Risk of major adverse cardiovascular events ofCYP2C19loss-of-function genotype guided prasugrel\/ticagrelor vs clopidogrel therapy for acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis. Platelets 32(5):591\u2013600. https:\/\/doi.org\/10.1080\/09537104.2020.1792871","journal-title":"Platelets"},{"issue":"8","key":"3998_CR171","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1111\/j.1538-7836.2010.03923.x","volume":"8","author":"MJ Sorich","year":"2010","unstructured":"Sorich MJ, Vitry A, Ward MB, Horowitz JD, McKinnon RA (2010) Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON\u2010TIMI 38 trial data. J Thromb Haemost 8(8):1678\u20131684. https:\/\/doi.org\/10.1111\/j.1538-7836.2010.03923.x","journal-title":"J Thromb Haemost"},{"issue":"7","key":"3998_CR172","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jcin.2023.01.356","volume":"16","author":"BS Ingraham","year":"2023","unstructured":"Ingraham BS, Farkouh ME, Lennon RJ, So D, Goodman SG, Geller N, Bae J-H, Jeong MH, Baudhuin LM, Mathew V, Bell MR, Lerman A, Fu Y-P, Hasan A, Iturriaga E, Tanguay J-F, Welsh RC, Rosenberg Y, Bailey K, Rihal C, Pereira NL (2023) Genetic-Guided Oral P2Y12 Inhibitor Selection and Cumulative Ischemic Events After Percutaneous Coronary Intervention. JACC: Cardiovasc Interventions 16(7):816\u2013825. https:\/\/doi.org\/10.1016\/j.jcin.2023.01.356","journal-title":"JACC: Cardiovasc Interventions"},{"key":"3998_CR173","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/978-3-642-29423-5_9","volume":"210","author":"MT Rondina","year":"2012","unstructured":"Rondina MT, Weyrich AS (2012) Targeting phosphodiesterases in anti-platelet therapy. Handb Exp Pharmacol 210:225\u2013238. https:\/\/doi.org\/10.1007\/978-3-642-29423-5_9","journal-title":"Handb Exp Pharmacol"},{"issue":"4","key":"3998_CR174","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1365-2125.2011.04034.x","volume":"72","author":"P Gresele","year":"2011","unstructured":"Gresele P, Momi S, Falcinelli E (2011) Anti-platelet therapy: phosphodiesterase inhibitors. Br J Clin Pharmacol 72(4):634\u2013646. https:\/\/doi.org\/10.1111\/j.1365-2125.2011.04034.x","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"3998_CR175","doi-asserted-by":"publisher","first-page":"395","DOI":"10.3109\/02652049609026026","volume":"13","author":"PW Murtagh","year":"1996","unstructured":"Murtagh PW, Deasy PB (1996) Combined dipyridamole and aspirin pellet formulation for improved oral drug delivery. Part 2: In-vivo evaluation and stability. J Microencapsul 13(4):395\u2013405. https:\/\/doi.org\/10.3109\/02652049609026026","journal-title":"J Microencapsul"},{"issue":"12","key":"3998_CR176","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1056\/NEJMoa0805002","volume":"359","author":"RL De Sacco","year":"2008","unstructured":"Sacco RL, Diener H-C, Yusuf S, Cotton D, \u00d4unpuu S, Lawton WA, Palesch Y, Martin RH, Albers GW, Bath P, Bornstein N, Chan BPL, Chen S-T, Cunha L, Dahl\u00f6f B, De Keyser J, Donnan GA, Estol C, Gorelick P, Gu V, Hermansson K, Hilbrich L, Kaste M, Lu C, Machnig T, Pais P, Roberts R, Skvortsova V, Teal P, Toni D, VanderMaelen C, Voigt T, Weber M, Yoon B-W (2008) Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke. N Engl J Med 359(12):1238\u20131251. https:\/\/doi.org\/10.1056\/NEJMoa0805002","journal-title":"N Engl J Med"},{"issue":"2","key":"3998_CR177","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1023\/B:THRO.0000003308.63022.8d","volume":"15","author":"K Schror","year":"2003","unstructured":"163.Schror K, Weber AA (2003) Comparative pharmacology of GP IIb\/IIIa antagonists. J Thromb Thrombolysis 15(2):71\u201380","journal-title":"J Thromb Thrombolysis"},{"issue":"4","key":"3998_CR178","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1365-2125.2010.03879.x","volume":"72","author":"DJ Schneider","year":"2011","unstructured":"Schneider DJ (2011) Anti-platelet therapy: glycoprotein IIb-IIIa antagonists. Br J Clin Pharmacol 72(4):672\u2013682. https:\/\/doi.org\/10.1111\/j.1365-2125.2010.03879.x","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"3998_CR179","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1592\/phco.22.5.380.33196","volume":"22","author":"C Pharand","year":"2002","unstructured":"Pharand C, Palisaitis DA, Hamel D (2002) Potential anaphylactic shock with abciximab readministration. Pharmacotherapy 22(3):380\u2013383","journal-title":"Pharmacotherapy"},{"key":"3998_CR180","doi-asserted-by":"publisher","unstructured":"Coughlin SR (2005) Protease-activated receptors in hemostasis, thrombosis and vascular biology. Journal of thrombosis and haemostasis: JTH 3. 8 1800\u20131814. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01377.x","DOI":"10.1111\/j.1538-7836.2005.01377.x"},{"issue":"1","key":"3998_CR181","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40268-016-0158-4","volume":"17","author":"RJ Gryka","year":"2017","unstructured":"Gryka RJ, Buckley LF, Anderson SM (2017) Vorapaxar: The Current Role and Future Directions of a Novel Protease-Activated Receptor Antagonist for Risk Reduction in Atherosclerotic Disease. Drugs R D 17(1):65\u201372. https:\/\/doi.org\/10.1007\/s40268-016-0158-4","journal-title":"Drugs R D"},{"issue":"1","key":"3998_CR182","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1177\/1074248417708617","volume":"23","author":"JY Moon","year":"2017","unstructured":"Moon JY, Franchi F, Rollini F, Angiolillo DJ (2017) Role for Thrombin Receptor Antagonism With Vorapaxar in Secondary Prevention of Atherothrombotic Events: From Bench to Bedside. J Cardiovasc Pharmacol Therap 23(1):23\u201337. https:\/\/doi.org\/10.1177\/1074248417708617","journal-title":"J Cardiovasc Pharmacol Therap"},{"issue":"15","key":"3998_CR183","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1056\/NEJMoa1200933","volume":"366","author":"DA Morrow","year":"2012","unstructured":"Morrow DA, Braunwald E, Bonaca MP, Ameriso SF, Dalby AJ, Fish MP, Fox KAA, Lipka LJ, Liu X, Nicolau JC, Ophuis AJO, Paolasso E, Scirica BM, Spinar J, Theroux P, Wiviott SD, Strony J, Murphy SA (2012) Vorapaxar in the Secondary Prevention of Atherothrombotic Events. N Engl J Med 366(15):1404\u20131413. https:\/\/doi.org\/10.1056\/NEJMoa1200933","journal-title":"N Engl J Med"},{"issue":"5","key":"3998_CR184","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2217\/fca-2019-0090","volume":"16","author":"US Tantry","year":"2020","unstructured":"Tantry US, Bliden KP, Chaudhary R, Novakovic M, Rout A, Gurbel PA (2020) Vorapaxar in the Treatment of Cardiovascular Diseases. Future Cardiol 16(5):373\u2013384.","journal-title":"Future Cardiol"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-03998-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-03998-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-03998-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T09:52:53Z","timestamp":1773309173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-03998-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":184,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["3998"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-03998-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"86"}}